| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP-dependent activity | HSPD1 ATP7A MYO5A NSF VPS4A ACSS1 DNAH2 SMC5 HELQ HSP90AA5P KIF20B ZRANB3 MYO5C DHX9 RAD50 ERCC6L2 TOR1B KIF5B DSCC1 DNAH5 HSPA14 TDRD12 | 1.66e-08 | 614 | 172 | 22 | GO:0140657 |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | HSPD1 ATP7A NSF VPS4A DNAH2 SMC5 HELQ HSP90AA5P KIF20B DHX9 RAD50 TOR1B KIF5B DNAH5 HSPA14 TDRD12 | 1.43e-06 | 441 | 172 | 16 | GO:0016887 |
| GeneOntologyMolecularFunction | pyrophosphatase activity | HSPD1 PRUNE2 ATP7A RNGTT NSF VPS4A TRPM2 DNAH2 SMC5 HELQ HSP90AA5P KIF20B DHX9 RAD50 GNA13 TOR1B KIF5B RAB1A DNAH5 HSPA14 TDRD12 | 1.16e-05 | 839 | 172 | 21 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | HSPD1 PRUNE2 ATP7A RNGTT NSF VPS4A TRPM2 DNAH2 SMC5 HELQ HSP90AA5P KIF20B DHX9 RAD50 GNA13 TOR1B KIF5B RAB1A DNAH5 HSPA14 TDRD12 | 1.18e-05 | 840 | 172 | 21 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | HSPD1 PRUNE2 ATP7A RNGTT NSF VPS4A TRPM2 DNAH2 SMC5 HELQ HSP90AA5P KIF20B DHX9 RAD50 GNA13 TOR1B KIF5B RAB1A DNAH5 HSPA14 TDRD12 | 1.18e-05 | 840 | 172 | 21 | GO:0016818 |
| GeneOntologyMolecularFunction | aspartic-type endopeptidase activity | 1.56e-05 | 37 | 172 | 5 | GO:0004190 | |
| GeneOntologyMolecularFunction | aspartic-type peptidase activity | 1.78e-05 | 38 | 172 | 5 | GO:0070001 | |
| GeneOntologyMolecularFunction | nucleotidyltransferase activity | 5.27e-05 | 152 | 172 | 8 | GO:0016779 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | HSPD1 ATP7A NSF VPS4A DNAH2 SMC5 HELQ HSP90AA5P KIF20B DHX9 RAD50 GNA13 TOR1B KIF5B RAB1A DNAH5 HSPA14 TDRD12 | 1.31e-04 | 775 | 172 | 18 | GO:0017111 |
| GeneOntologyMolecularFunction | DNA helicase activity | 1.95e-04 | 62 | 172 | 5 | GO:0003678 | |
| GeneOntologyMolecularFunction | single-stranded 3'-5' DNA helicase activity | 2.20e-04 | 3 | 172 | 2 | GO:1990518 | |
| GeneOntologyMolecularFunction | helicase activity | 4.46e-04 | 158 | 172 | 7 | GO:0004386 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | 4.60e-04 | 262 | 172 | 9 | GO:0140097 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 5.56e-04 | 118 | 172 | 6 | GO:0003774 | |
| GeneOntologyMolecularFunction | RNA stem-loop binding | 7.45e-04 | 21 | 172 | 3 | GO:0035613 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 8.19e-04 | 127 | 172 | 6 | GO:0008094 | |
| GeneOntologyMolecularFunction | single-stranded DNA helicase activity | 9.80e-04 | 23 | 172 | 3 | GO:0017116 | |
| GeneOntologyMolecularFunction | ATP-dependent protein disaggregase activity | 1.08e-03 | 6 | 172 | 2 | GO:0140545 | |
| GeneOntologyMolecularFunction | single-stranded DNA binding | 1.08e-03 | 134 | 172 | 6 | GO:0003697 | |
| GeneOntologyMolecularFunction | GTPase binding | ROCK2 ATP7A MYO5A NSF VPS4A SPTBN1 GCC2 RAB11FIP4 DENND5A SORL1 | 1.16e-03 | 360 | 172 | 10 | GO:0051020 |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | ROCK2 MYO5A ACTR3C IFT81 SPTBN1 BBS4 PANX1 NEB CLSTN1 MAP10 YWHAH KIF20B MYO5C FARP2 BRCA2 TOR1B KIF5B UTRN CAP2 NIN | 1.28e-03 | 1099 | 172 | 20 | GO:0008092 |
| GeneOntologyMolecularFunction | small GTPase binding | 1.91e-03 | 321 | 172 | 9 | GO:0031267 | |
| GeneOntologyBiologicalProcess | cell division | ROCK2 MACC1 DR1 TOPAZ1 VPS4A SPTBN1 BBS4 SMC5 MAP10 KIF20B SYCP2 MIS12 BRCA2 ANAPC1 SGO2 ZFYVE26 PADI6 RAB11FIP4 TACC3 TDRD12 | 1.30e-06 | 697 | 170 | 20 | GO:0051301 |
| GeneOntologyBiologicalProcess | mitotic cell cycle process | ROCK2 VPS4A CAMK2G SPTBN1 USP29 BBS4 CHEK1 SMC5 MAP10 YWHAH CREB3L1 KIF20B RAD50 USP26 MIS12 UBXN2B BRCA2 ANAPC1 HASPIN ZFYVE26 TACC3 | 7.76e-06 | 854 | 170 | 21 | GO:1903047 |
| GeneOntologyBiologicalProcess | regulation of cytokinesis | 1.80e-05 | 99 | 170 | 7 | GO:0032465 | |
| GeneOntologyBiologicalProcess | cell cycle process | ROCK2 VPS4A KIZ CAMK2G SPTBN1 USP29 BBS4 CHEK1 SMC5 MAP10 YWHAH CREB3L1 KIF20B RAD50 USP26 SYCP2 MIS12 UBXN2B BRCA2 ANAPC1 HASPIN SGO2 ZFYVE26 RAB11FIP4 TACC3 DSCC1 TDRD12 NIN | 1.87e-05 | 1441 | 170 | 28 | GO:0022402 |
| GeneOntologyBiologicalProcess | mitotic cell cycle | ROCK2 ZNF268 VPS4A CAMK2G SPTBN1 USP29 BBS4 CHEK1 SMC5 MAP10 YWHAH CREB3L1 KIF20B RAD50 USP26 MIS12 UBXN2B BRCA2 ANAPC1 HASPIN ZFYVE26 TACC3 | 3.22e-05 | 1014 | 170 | 22 | GO:0000278 |
| GeneOntologyBiologicalProcess | regulation of cell division | 4.52e-05 | 201 | 170 | 9 | GO:0051302 | |
| GeneOntologyBiologicalProcess | cytokinesis | ROCK2 VPS4A SPTBN1 BBS4 MAP10 KIF20B BRCA2 ZFYVE26 RAB11FIP4 | 5.07e-05 | 204 | 170 | 9 | GO:0000910 |
| GeneOntologyBiologicalProcess | biological phase | 7.47e-05 | 53 | 170 | 5 | GO:0044848 | |
| GeneOntologyBiologicalProcess | DNA-templated DNA replication | 1.17e-04 | 178 | 170 | 8 | GO:0006261 | |
| GeneOntologyBiologicalProcess | viral process | VPS4A ERVK-9 ERVK-10 SMC5 IFIT1 DHX9 RAD50 MGAT5 ERVK-8 ERVK-19 ERVK-24 RAB1A TRIM38 | 1.29e-04 | 464 | 170 | 13 | GO:0016032 |
| GeneOntologyBiologicalProcess | mitotic cytokinesis | 1.36e-04 | 95 | 170 | 6 | GO:0000281 | |
| GeneOntologyBiologicalProcess | chromosome organization | VPS4A HAT1 SMC5 MAP10 HELQ ZRANB3 DHX9 RAD50 SYCP2 MIS12 BRCA2 ANAPC1 HASPIN SGO2 TACC3 DSCC1 | 1.83e-04 | 686 | 170 | 16 | GO:0051276 |
| GeneOntologyBiologicalProcess | maintenance of sister chromatid cohesion | 1.87e-04 | 14 | 170 | 3 | GO:0034086 | |
| GeneOntologyBiologicalProcess | regulation of cell cycle process | ROCK2 VPS4A BBS4 CHEK1 SMC5 MAP10 YWHAH CREB3L1 KIF20B RAD50 UBXN2B BRCA2 ANAPC1 HASPIN SGO2 ZFYVE26 RAB11FIP4 TACC3 | 2.21e-04 | 845 | 170 | 18 | GO:0010564 |
| GeneOntologyBiologicalProcess | telomere maintenance via recombination | 2.33e-04 | 15 | 170 | 3 | GO:0000722 | |
| GeneOntologyBiologicalProcess | DNA recombination | HSPD1 CHEK1 ERVK-10 SMC5 HELQ ZRANB3 RAD50 BRCA2 ERVK-8 ZFYVE26 POLN | 2.48e-04 | 368 | 170 | 11 | GO:0006310 |
| GeneOntologyBiologicalProcess | protein localization to organelle | HSPD1 ROCK2 NUP50 SGTB VPS4A BBS4 SRP68 GRIN2A SMC5 KIF20B DHX9 UBXN2B BRCA2 GCC2 HASPIN TOMM34 KCNQ3 TOR1B NUP188 GOLGB1 SORL1 | 2.61e-04 | 1091 | 170 | 21 | GO:0033365 |
| GeneOntologyBiologicalProcess | DNA replication | CHEK1 ERVK-10 ZRANB3 DHX9 RAD50 BRCA2 BAZ1A ERVK-8 POLN DSCC1 | 2.74e-04 | 312 | 170 | 10 | GO:0006260 |
| GeneOntologyCellularComponent | centrosome | ROCK2 VPS4A KIZ IFT81 LRRC49 CCDC18 TENT5C BBS4 CHEK1 ECPAS MAP10 CCDC38 KIF20B DHX9 UBXN2B BRCA2 HASPIN ERCC6L2 ZFYVE26 KIF5B RAB11FIP4 TACC3 NIN | 8.33e-08 | 770 | 171 | 23 | GO:0005813 |
| GeneOntologyCellularComponent | microtubule organizing center | ROCK2 VPS4A KIZ IFT81 LRRC49 CCDC18 TENT5C BBS4 CHEK1 ECPAS MAP10 CCDC38 KIF20B DHX9 UBXN2B TM9SF2 BRCA2 HASPIN ERCC6L2 ZFYVE26 KIF5B RAB11FIP4 TACC3 NIN | 4.97e-07 | 919 | 171 | 24 | GO:0005815 |
| GeneOntologyCellularComponent | 9+2 motile cilium | 1.56e-04 | 238 | 171 | 9 | GO:0097729 | |
| GeneOntologyCellularComponent | spindle pole | 2.93e-04 | 205 | 171 | 8 | GO:0000922 | |
| GeneOntologyCellularComponent | sperm flagellum | 3.91e-04 | 214 | 171 | 8 | GO:0036126 | |
| Domain | TPR_8 | 6.14e-06 | 53 | 161 | 6 | PF13181 | |
| Domain | TPR-contain_dom | 6.18e-06 | 150 | 161 | 9 | IPR013026 | |
| Domain | TPR_1 | 1.27e-05 | 90 | 161 | 7 | IPR001440 | |
| Domain | TPR_1 | 1.27e-05 | 90 | 161 | 7 | PF00515 | |
| Domain | - | NAA15 SGTB RPAP3 BBS4 SRP68 IFIT1 IFIT3 IFIT1B PDCD11 TOMM34 | 1.28e-05 | 207 | 161 | 10 | 1.25.40.10 |
| Domain | TPR_REGION | 1.34e-05 | 165 | 161 | 9 | PS50293 | |
| Domain | TPR | 1.34e-05 | 165 | 161 | 9 | PS50005 | |
| Domain | TPR | 1.61e-05 | 129 | 161 | 8 | SM00028 | |
| Domain | TPR_repeat | 2.02e-05 | 133 | 161 | 8 | IPR019734 | |
| Domain | TPR-like_helical_dom | NAA15 SGTB RPAP3 BBS4 SRP68 IFIT1 IFIT3 IFIT1B PDCD11 TOMM34 | 3.53e-05 | 233 | 161 | 10 | IPR011990 |
| Domain | IFRD_C | 7.39e-05 | 2 | 161 | 2 | PF04836 | |
| Domain | IFRD | 7.39e-05 | 2 | 161 | 2 | PF05004 | |
| Domain | Interferon-rel_develop_reg_C | 7.39e-05 | 2 | 161 | 2 | IPR006921 | |
| Domain | Interferon-rel_develop_reg_N | 7.39e-05 | 2 | 161 | 2 | IPR007701 | |
| Domain | USP37-like_PH | 2.20e-04 | 3 | 161 | 2 | IPR032069 | |
| Domain | UCH_N | 2.20e-04 | 3 | 161 | 2 | PF16674 | |
| Domain | P-loop_NTPase | MYO5A NSF VPS4A DNAH2 SMC5 HELQ KIF20B ZRANB3 MYO5C DHX9 RAD50 GNA13 ERCC6L2 TOR1B KIF5B RAB1A DNAH5 TDRD12 | 3.85e-04 | 848 | 161 | 18 | IPR027417 |
| Domain | - | 4.38e-04 | 4 | 161 | 2 | 3.90.1460.10 | |
| Domain | DUF1693 | 4.38e-04 | 4 | 161 | 2 | IPR012937 | |
| Domain | GTF2I | 4.38e-04 | 4 | 161 | 2 | PS51139 | |
| Domain | GTF2I | 4.38e-04 | 4 | 161 | 2 | PF02946 | |
| Domain | DUF1693 | 4.38e-04 | 4 | 161 | 2 | SM01153 | |
| Domain | GTF2I | 4.38e-04 | 4 | 161 | 2 | IPR004212 | |
| Domain | NTP_transf_7 | 4.38e-04 | 4 | 161 | 2 | PF07984 | |
| Domain | NUT | 7.26e-04 | 5 | 161 | 2 | IPR024310 | |
| Domain | NUT_N | 7.26e-04 | 5 | 161 | 2 | IPR024309 | |
| Domain | NUT | 7.26e-04 | 5 | 161 | 2 | PF12881 | |
| Domain | Myosin_S1_N | 7.26e-04 | 5 | 161 | 2 | IPR008989 | |
| Domain | Dilute_dom | 1.08e-03 | 6 | 161 | 2 | IPR002710 | |
| Domain | DIL | 1.08e-03 | 6 | 161 | 2 | PF01843 | |
| Domain | DILUTE | 1.08e-03 | 6 | 161 | 2 | PS51126 | |
| Domain | DIL | 1.08e-03 | 6 | 161 | 2 | SM01132 | |
| Domain | C1_1 | 1.47e-03 | 57 | 161 | 4 | PF00130 | |
| Domain | TPR_11 | 1.51e-03 | 7 | 161 | 2 | PF13414 | |
| Pubmed | CASP8AP2 LCORL RPAP3 CAMK2G LRRC49 ICE1 ZDBF2 CHEK1 ECPAS KIF20B RAD50 RLF BRCA2 ANAPC1 GCC2 TACC3 UTRN GOLGB1 | 3.79e-12 | 418 | 172 | 18 | 34709266 | |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | KBTBD6 NSF VPS4A CAMK2G RPS12 USP29 HAT1 SRP68 ICE1 PFDN5 YWHAH RAD50 USP26 USP5 UBXN2B GCC2 GNA13 IFRD2 POLR1B ALB KIF5B NUP188 UTRN NIN | 2.04e-10 | 1005 | 172 | 24 | 19615732 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | HSPD1 NUP50 RPL37A NSF VPS4A SPTBN1 RPS12 HAT1 SRP68 ECPAS CCDC38 DHX9 RAD50 TM9SF2 BAZ1A ANAPC1 GLYR1 PDCD11 SGO2 KIF5B NUP188 RAB1A DNAH5 MCOLN2 | 1.66e-07 | 1425 | 172 | 24 | 30948266 |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | HSPD1 ROCK2 DR1 RPL37A NAA15 CAMK2G SPTBN1 RPS12 DNAH2 HAT1 PFDN5 HSP90AA5P YWHAH RAD50 USP5 KIF5B UTRN GOLGB1 | 2.46e-07 | 847 | 172 | 18 | 35235311 |
| Pubmed | 4.74e-07 | 4 | 172 | 3 | 17079283 | ||
| Pubmed | 4.74e-07 | 4 | 172 | 3 | 8660659 | ||
| Pubmed | Interferon-induced Ifit proteins: their role in viral pathogenesis. | 4.74e-07 | 4 | 172 | 3 | 25428874 | |
| Pubmed | 4.74e-07 | 4 | 172 | 3 | 37496288 | ||
| Pubmed | ARID4B KBTBD6 IFT81 CCDC18 HAT1 SRP68 RAD50 RLF GLYR1 SGO2 ALB KIF5B UTRN CAP2 NIN | 8.58e-07 | 645 | 172 | 15 | 25281560 | |
| Pubmed | NAA15 MYO5A SPTBN1 RPS12 SRP68 ECPAS RAD50 USP5 ANAPC1 PHF3 GLYR1 PDCD11 KIF5B NUP188 UTRN | 9.99e-07 | 653 | 172 | 15 | 22586326 | |
| Pubmed | Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation. | 1.04e-06 | 208 | 172 | 9 | 33230847 | |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | HSPD1 RPL37A NAA15 MYO5A NSF VPS4A CAMK2G SPTBN1 RPS12 HAT1 SRP68 PFDN5 IDI1 ECPAS YWHAH DHX9 RAD50 USP5 KIF5B RAB1A | 1.18e-06 | 1149 | 172 | 20 | 35446349 |
| Pubmed | 1.18e-06 | 5 | 172 | 3 | 27137933 | ||
| Pubmed | The broad-spectrum antiviral functions of IFIT and IFITM proteins. | 2.35e-06 | 6 | 172 | 3 | 23237964 | |
| Pubmed | HSPD1 NAA15 SETD1B SPTBN1 RPS12 SRP68 ECPAS PARP14 DHX9 PDCD11 TOMM34 KIF5B RAB1A UTRN GOLGB1 | 2.83e-06 | 711 | 172 | 15 | 33022573 | |
| Pubmed | Network organization of the huntingtin proteomic interactome in mammalian brain. | HSPD1 ROCK2 MYO5A NSF CAMK2G SPTBN1 GRIN2A YWHAH DHX9 USP5 BRCA2 GNA13 KIF5B RAB1A | 2.89e-06 | 621 | 172 | 14 | 22794259 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | HSPD1 NAA15 SETD1B MYO5A RPAP3 VPS4A CAMK2G SPTBN1 SRP68 KIF20B DHX9 RAD50 RLF USP5 BAZ1A GLYR1 PDCD11 POLR1B PRR14L KIF5B UTRN | 3.78e-06 | 1353 | 172 | 21 | 29467282 |
| Pubmed | Transcriptional landscape of pulmonary lymphatic endothelial cells during fetal gestation. | 4.10e-06 | 7 | 172 | 3 | 31083674 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | HSPD1 NAA15 MYO5A RPAP3 CAMK2G SPTBN1 RPS12 SRP68 YWHAH KIF20B DHX9 RAD50 PHF3 CLK3 GLYR1 PDCD11 POLR1B ALB KIF5B HSPA14 | 4.55e-06 | 1257 | 172 | 20 | 36526897 |
| Pubmed | HSPD1 RALGAPA1 CASP8AP2 RPL37A ATP7A NAA15 MYO5A RPAP3 NSF IFT81 SPTBN1 RPS12 CCDC18 PFDN5 DHX9 GLYR1 PDCD11 TOMM34 HSPA14 VPS13B GOLGB1 NIN | 4.69e-06 | 1487 | 172 | 22 | 33957083 | |
| Pubmed | Lupus nephritis susceptibility loci in women with systemic lupus erythematosus. | 4.75e-06 | 23 | 172 | 4 | 24925725 | |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | NAA15 NSF VPS4A DNAH2 HAT1 SRP68 ECPAS CLSTN1 YWHAH USP5 IFRD1 TM9SF2 KIF5B NUP188 PLG RAB1A HSPA14 | 4.88e-06 | 942 | 172 | 17 | 31073040 |
| Pubmed | HSPD1 CASP8AP2 RPL37A NSF SPTBN1 DNAH2 SRP68 ECPAS IFIT1 RAD50 USP5 BRCA2 GLYR1 ALB GOLGB1 | 5.74e-06 | 754 | 172 | 15 | 35906200 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | HSPD1 NUP50 ARID4B NUTM2A RPS12 ICE1 ZDBF2 SMC5 KIF20B DHX9 IFRD1 BRCA2 NUTM2B BAZ1A PHF3 PDCD11 SGO2 | 5.76e-06 | 954 | 172 | 17 | 36373674 |
| Pubmed | HSPD1 ATP7A NAA15 MYO5A CAMK2G RPS12 PANX1 ECPAS PARP14 DHX9 RAD50 CLK3 GCC2 GNA13 TOMM34 KIF5B NUP188 HSPA14 GOLGB1 | 5.85e-06 | 1168 | 172 | 19 | 19946888 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | HSPD1 ARID4B NSF ZNF268 IFT81 ECPAS RAD50 IFRD1 BAZ1A ANAPC1 GLYR1 PITX2 ALB KIF5B HSPA14 SORL1 | 6.16e-06 | 857 | 172 | 16 | 25609649 |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | HSPD1 ROCK2 NUP50 NAA15 RNGTT NSF PFDN5 CHEK1 IDI1 ECPAS YWHAH RAD50 USP5 TOMM34 NUP188 UTRN SORL1 | 7.55e-06 | 974 | 172 | 17 | 28675297 |
| Pubmed | A revised nomenclature for transcribed human endogenous retroviral loci. | 7.61e-06 | 94 | 172 | 6 | 21542922 | |
| Pubmed | 9.77e-06 | 9 | 172 | 3 | 25857663 | ||
| Pubmed | 9.77e-06 | 9 | 172 | 3 | 30380406 | ||
| Pubmed | HSPD1 ROCK2 MACC1 DR1 MYO5A CAMK2G IFT81 SPTBN1 RPS12 DNAH2 NEB YWHAH GTF2IRD2B BAZ1A SLC22A14 GNA13 GTF2IRD2 PADI6 KIF5B RAB1A GOLGB1 | 9.98e-06 | 1442 | 172 | 21 | 35575683 | |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | ROCK2 NUP50 NAA15 NANP NSF SPTBN1 HAT1 SRP68 ECPAS IFIT1 YWHAH RAD50 USP5 PDCD11 TOMM34 KIF5B TACC3 RAB1A UTRN GOLGB1 | 1.54e-05 | 1367 | 172 | 20 | 32687490 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | RALGAPA1 PRUNE2 MYO5A ACTR3C KIZ TRPM2 DGKH ECPAS FARP2 RLF IFRD1 GCC2 GLYR1 ANKRD12 DENND5A UTRN RECK VPS13B GOLGB1 CAP2 FAM149A | 1.61e-05 | 1489 | 172 | 21 | 28611215 |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | HSPD1 RNGTT TOPAZ1 DNAH2 SRP68 DGKH ICE1 ECPAS PARP14 DHX9 ALB NUP188 PCDH10 UTRN | 1.95e-05 | 736 | 172 | 14 | 29676528 |
| Pubmed | 2.30e-05 | 305 | 172 | 9 | 33194618 | ||
| Pubmed | 2.33e-05 | 234 | 172 | 8 | 36243803 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 30777093 | ||
| Pubmed | Ligation of CD200R by CD200 is not required for normal murine myelopoiesis. | 2.43e-05 | 2 | 172 | 2 | 17803680 | |
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 28007458 | ||
| Pubmed | A Critical Role for CD200R Signaling in Limiting the Growth and Metastasis of CD200+ Melanoma. | 2.43e-05 | 2 | 172 | 2 | 27385779 | |
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 36446235 | ||
| Pubmed | SGOL2 promotes prostate cancer progression by inhibiting RAB1A ubiquitination. | 2.43e-05 | 2 | 172 | 2 | 36566018 | |
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 23824812 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 27823966 | ||
| Pubmed | A viral RNA structural element alters host recognition of nonself RNA. | 2.43e-05 | 2 | 172 | 2 | 24482115 | |
| Pubmed | Sequestration by IFIT1 impairs translation of 2'O-unmethylated capped RNA. | 2.43e-05 | 2 | 172 | 2 | 24098121 | |
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 23097187 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 24170042 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 25927359 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 30282041 | ||
| Pubmed | CD200R1 Contributes to Successful Functional Reinnervation after a Sciatic Nerve Injury. | 2.43e-05 | 2 | 172 | 2 | 35681481 | |
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 26157117 | ||
| Pubmed | CD200R1 regulates eosinophilia during pulmonary fungal infection in mice. | 2.43e-05 | 2 | 172 | 2 | 31365119 | |
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 7557095 | ||
| Pubmed | The CD200 receptor is a novel and potent regulator of murine and human mast cell function. | 2.43e-05 | 2 | 172 | 2 | 15661892 | |
| Pubmed | Human myosin-Vc is a novel class V myosin expressed in epithelial cells. | 2.43e-05 | 2 | 172 | 2 | 11870218 | |
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 26459629 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 22589727 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 33454014 | ||
| Pubmed | Analysis of albumin-associated peptides and proteins from ovarian cancer patients. | 2.43e-05 | 2 | 172 | 2 | 16099937 | |
| Pubmed | FAM46B is a prokaryotic-like cytoplasmic poly(A) polymerase essential in human embryonic stem cells. | 2.43e-05 | 2 | 172 | 2 | 32009146 | |
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 22204814 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 18555631 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 16338116 | ||
| Pubmed | Identification and validation of Ifit1 as an important innate immune bottleneck. | 2.43e-05 | 2 | 172 | 2 | 22745654 | |
| Pubmed | Characterization of human cd200 glycoprotein receptor gene located on chromosome 3q12-13. | 2.43e-05 | 2 | 172 | 2 | 12853143 | |
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 9722946 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 17667818 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 31073183 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 27240734 | ||
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 33823877 | ||
| Pubmed | Identification of the Isoform-specific Interactions between the Tail and the Head of Class V Myosin. | 2.43e-05 | 2 | 172 | 2 | 26912658 | |
| Pubmed | Comparison of TFII-I gene family members deleted in Williams-Beuren syndrome. | 2.43e-05 | 2 | 172 | 2 | 15388857 | |
| Pubmed | 2.43e-05 | 2 | 172 | 2 | 34952004 | ||
| Pubmed | ROCK2 NAA15 RPAP3 NSF VPS4A HAT1 SRP68 ECPAS IFIT1 DHX9 IFRD1 PITX2 KIF5B | 2.44e-05 | 653 | 172 | 13 | 33742100 | |
| Pubmed | 2.53e-05 | 12 | 172 | 3 | 14557543 | ||
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | RNGTT ARID4B MYO5A SRP68 SMC5 KIF20B DHX9 BAZ1A PHF3 GLYR1 PDCD11 SGO2 POLR1B HSPA14 | 2.73e-05 | 759 | 172 | 14 | 35915203 |
| Pubmed | 2.74e-05 | 312 | 172 | 9 | 37120454 | ||
| Pubmed | RPL37A RNGTT ARID4B RPS12 HAT1 SRP68 PFDN5 CHEK1 YWHAH DHX9 RLF IFRD1 ANAPC1 PITX2 PDCD11 PCDH10 | 2.84e-05 | 971 | 172 | 16 | 33306668 | |
| Pubmed | HSPD1 ROCK2 RALGAPA1 MYO5A ACTR3C NSF CAMK2G LRRC49 SPTBN1 SRP68 GRIN2A YWHAH DHX9 USP5 MTERF2 KCNQ3 ALB KIF5B RAB1A UTRN | 2.95e-05 | 1431 | 172 | 20 | 37142655 | |
| Pubmed | HSPD1 CASP8AP2 DR1 ARID4B SPTBN1 NEB YWHAH VAV3 KIF5B GOLGB1 CAP2 | 3.32e-05 | 486 | 172 | 11 | 20936779 | |
| Pubmed | 3.54e-05 | 403 | 172 | 10 | 30562941 | ||
| Pubmed | Analysis of the Histone H3.1 Interactome: A Suitable Chaperone for the Right Event. | 3.62e-05 | 182 | 172 | 7 | 26527279 | |
| Pubmed | The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation. | ARID4B SPTBN1 RPS12 ZDBF2 YWHAH DHX9 RAD50 BAZ1A PHF3 PITX2 PDCD11 ALB | 3.66e-05 | 583 | 172 | 12 | 29844126 |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | HSPD1 ROCK2 PRUNE2 NUP50 DR1 NAA15 SPTBN1 RPS12 HAT1 SRP68 PFDN5 ECPAS YWHAH DHX9 USP5 TOMM34 KIF5B NUP188 RAB1A CAP2 | 3.73e-05 | 1455 | 172 | 20 | 22863883 |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | CASP8AP2 SETD1B RNGTT ZDBF2 KIF20B RAD50 BRCA2 ANAPC1 DSCC1 GOLGB1 SORL1 NIN | 3.98e-05 | 588 | 172 | 12 | 38580884 |
| Pubmed | The P-body component USP52/PAN2 is a novel regulator of HIF1A mRNA stability. | 4.05e-05 | 328 | 172 | 9 | 23398456 | |
| Pubmed | 4.16e-05 | 14 | 172 | 3 | 7622488 | ||
| Pubmed | O-GlcNAcylation of SPOP promotes carcinogenesis in hepatocellular carcinoma. | 4.17e-05 | 254 | 172 | 8 | 36604567 | |
| Pubmed | 4.28e-05 | 255 | 172 | 8 | 15324660 | ||
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | 4.44e-05 | 332 | 172 | 9 | 32786267 | |
| Pubmed | STUB1 is targeted by the SUMO-interacting motif of EBNA1 to maintain Epstein-Barr Virus latency. | 5.08e-05 | 192 | 172 | 7 | 32176739 | |
| Pubmed | 5.34e-05 | 340 | 172 | 9 | 29478914 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | HSPD1 MYO5A NSF YWHAH MYO5C DHX9 RAD50 BAZ1A GNA13 PDCD11 ALB KIF5B NUP188 RAB1A UTRN GOLGB1 | 5.34e-05 | 1024 | 172 | 16 | 24711643 |
| Pubmed | HSPD1 ROCK2 RALGAPA1 ATP7A RPAP3 NSF SPTBN1 SRP68 ECPAS DHX9 ARHGAP29 KIF5B GOLGB1 | 5.58e-05 | 708 | 172 | 13 | 39231216 | |
| Pubmed | TXLNA enhances TBK1 phosphorylation by suppressing PPM1B recruitment. | 6.72e-05 | 138 | 172 | 6 | 37506885 | |
| Pubmed | 6.74e-05 | 272 | 172 | 8 | 31010829 | ||
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 6.99e-05 | 202 | 172 | 7 | 33005030 | |
| Pubmed | 7.27e-05 | 3 | 172 | 2 | 18164423 | ||
| Pubmed | The CD200-CD200R1 inhibitory signaling pathway: immune regulation and host-pathogen interactions. | 7.27e-05 | 3 | 172 | 2 | 24388216 | |
| Interaction | PHF21A interactions | CASP8AP2 RPAP3 CAMK2G LRRC49 ICE1 ZDBF2 ECPAS KIF20B RAD50 RLF BRCA2 ANAPC1 GCC2 TACC3 UTRN GOLGB1 | 2.85e-08 | 343 | 167 | 16 | int:PHF21A |
| Interaction | KDM1A interactions | CASP8AP2 LCORL RPAP3 CAMK2G LRRC49 ICE1 ZDBF2 PFDN5 CCDC172 CHEK1 ECPAS KIF20B RAD50 RLF STX19 BRCA2 ANAPC1 GCC2 GLYR1 ARHGAP29 KIF5B TACC3 UTRN GOLGB1 NIN | 2.52e-07 | 941 | 167 | 25 | int:KDM1A |
| Interaction | POLR1E interactions | RPAP3 CAMK2G IFT81 LRRC49 ICE1 ZDBF2 RAD50 RLF BRCA2 BAZ1A PDCD11 SGO2 POLR1B NUP188 | 1.37e-06 | 350 | 167 | 14 | int:POLR1E |
| Interaction | NDC80 interactions | ROCK2 KIZ IFT81 LRRC49 CCDC18 ICE1 MYO5C RAD50 MIS12 PHF3 GCC2 PDCD11 NIN | 2.12e-06 | 312 | 167 | 13 | int:NDC80 |
| Interaction | TMOD1 interactions | 8.08e-06 | 161 | 167 | 9 | int:TMOD1 | |
| Interaction | HNRNPCL2 interactions | ROCK2 CAMK2G SMC5 RAD50 FARP2 BAZ1A CLK3 HASPIN PDCD11 DSCC1 HSPA14 | 1.86e-05 | 274 | 167 | 11 | int:HNRNPCL2 |
| Interaction | HELQ interactions | 1.99e-05 | 20 | 167 | 4 | int:HELQ | |
| Interaction | IFIT1B interactions | 3.04e-05 | 8 | 167 | 3 | int:IFIT1B | |
| Interaction | KCNA3 interactions | HSPD1 ROCK2 RALGAPA1 ATP7A RPAP3 NSF SPTBN1 SRP68 ECPAS HELQ MYO5C DHX9 RAD50 PHF3 ARHGAP29 KIF5B DNAH5 GOLGB1 SORL1 TDRD12 | 3.68e-05 | 871 | 167 | 20 | int:KCNA3 |
| Cytoband | 1p22.1 | 2.37e-04 | 32 | 172 | 3 | 1p22.1 | |
| Cytoband | 10q23.31 | 2.84e-04 | 34 | 172 | 3 | 10q23.31 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 5.41e-06 | 115 | 107 | 7 | 769 | |
| GeneFamily | Myosins, class V | 1.04e-04 | 3 | 107 | 2 | 1100 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 1.42e-03 | 206 | 107 | 6 | 682 | |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | CASP8AP2 NAA15 ARID4B MYO5A RPAP3 ZNF268 IDI1 ZNF354B KIF20B RAD50 RLF BAZ1A PHF3 GCC2 KIF5B ZNF85 ZNF654 GOLGB1 SORL1 NIN | 7.27e-09 | 656 | 166 | 20 | M18979 |
| Coexpression | FISCHER_DREAM_TARGETS | HSPD1 CASP8AP2 NUP50 DR1 NAA15 LCORL CCDC18 HAT1 CHEK1 SMC5 KIF20B ZRANB3 IFRD1 MIS12 BRCA2 ANAPC1 IFRD2 HASPIN SGO2 ZNF85 TACC3 DSCC1 | 2.27e-07 | 969 | 166 | 22 | M149 |
| Coexpression | LI_ESTROGENE_NON_MCF7_T47D_E2_RESPONSE_UP | 3.46e-06 | 17 | 166 | 4 | M48223 | |
| Coexpression | GEORGES_TARGETS_OF_MIR192_AND_MIR215 | RPAP3 NSF SPTBN1 CCDC18 PANX1 IDI1 CLSTN1 KIF20B IFRD1 MIS12 BRCA2 HASPIN ARHGAP29 SGO2 TOR1B KIF5B ZNF85 RAB1A NIN | 4.09e-06 | 892 | 166 | 19 | M18120 |
| Coexpression | GSE13762_CTRL_VS_125_VITAMIND_DAY12_DC_UP | 4.85e-06 | 148 | 166 | 8 | M1892 | |
| Coexpression | HALLMARK_G2M_CHECKPOINT | 5.52e-06 | 200 | 166 | 9 | M5901 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | RALGAPA1 DR1 RPL37A ARID4B MYO5A PECAM1 RPS12 ICE1 PFDN5 ODC1 IDI1 SMC5 PARP14 DHX9 SLAMF6 BAZ1A PLEKHO2 PHF3 GNA13 VAV3 UTRN TRIM38 VPS13B SORL1 NIN | 8.14e-06 | 1492 | 166 | 25 | M40023 |
| Coexpression | JOHANSSON_BRAIN_CANCER_EARLY_VS_LATE_UP | 8.57e-06 | 7 | 166 | 3 | M1239 | |
| Coexpression | JOHANSSON_BRAIN_CANCER_EARLY_VS_LATE_UP | 8.57e-06 | 7 | 166 | 3 | MM1117 | |
| Coexpression | MARSON_BOUND_BY_E2F4_UNSTIMULATED | CASP8AP2 NUP50 LRRC49 CHEK1 HELQ TENT5B USP5 MIS12 BRCA2 PLEKHO2 HASPIN SGO2 TACC3 POLN DSCC1 HSPA14 | 1.33e-05 | 714 | 166 | 16 | M1744 |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP | HSPD1 NAA15 RNGTT LCORL RPAP3 CHEK1 IFIT3 KIF20B DHX9 RAD50 RLF IFRD1 BRCA2 ANAPC1 SGO2 KIF5B | 1.49e-05 | 721 | 166 | 16 | M10237 |
| Coexpression | GSE13547_CTRL_VS_ANTI_IGM_STIM_BCELL_2H_UP | 2.28e-05 | 183 | 166 | 8 | M2993 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C4_CYCLING_T_CELL | ERVH48-1 CASP8AP2 NUP50 CAMK2G CCDC18 HAT1 CHEK1 SMC5 KIF20B CD200R1 USP5 BRCA2 SGO2 ZNF85 NUP188 TACC3 DSCC1 NIN | 3.03e-05 | 939 | 166 | 18 | M45768 |
| Coexpression | GSE411_UNSTIM_VS_400MIN_IL6_STIM_SOCS3_KO_MACROPHAGE_UP | 4.15e-05 | 199 | 166 | 8 | M6001 | |
| Coexpression | GSE36888_STAT5_AB_KNOCKIN_VS_WT_TCELL_IL2_TREATED_17H_UP | 4.15e-05 | 199 | 166 | 8 | M8748 | |
| Coexpression | GSE11961_MEMORY_BCELL_DAY7_VS_PLASMA_CELL_DAY7_DN | 4.30e-05 | 200 | 166 | 8 | M9368 | |
| Coexpression | GSE26890_CXCR1_NEG_VS_POS_EFFECTOR_CD8_TCELL_UP | 4.30e-05 | 200 | 166 | 8 | M8559 | |
| Coexpression | GSE15930_NAIVE_VS_72H_IN_VITRO_STIM_IFNAB_CD8_TCELL_DN | 4.30e-05 | 200 | 166 | 8 | M3613 | |
| Coexpression | GSE44649_NAIVE_VS_ACTIVATED_CD8_TCELL_MIR155_KO_DN | 4.30e-05 | 200 | 166 | 8 | M9777 | |
| Coexpression | GSE7852_LN_VS_THYMUS_TCONV_DN | 4.30e-05 | 200 | 166 | 8 | M5746 | |
| Coexpression | WEI_MYCN_TARGETS_WITH_E_BOX | DR1 NAA15 MYO5A HAT1 CHEK1 ODC1 IDI1 YWHAH DHX9 USP5 BAZ1A TOMM34 SGO2 POLR1B DSCC1 HSPA14 | 4.63e-05 | 792 | 166 | 16 | M12113 |
| Coexpression | MENON_FETAL_KIDNEY_9_ENDOTHELIAL_CELLS | 4.80e-05 | 102 | 166 | 6 | M39259 | |
| Coexpression | BLANCO_MELO_SARS_COV_1_INFECTION_MCR5_CELLS_UP | 5.26e-05 | 12 | 166 | 3 | M34000 | |
| Coexpression | LAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_LARGE_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_UP | CASP8AP2 CCDC18 HAT1 CHEK1 KIF20B ZRANB3 BRCA2 HASPIN SGO2 TACC3 DSCC1 | 5.43e-05 | 402 | 166 | 11 | MM454 |
| Coexpression | GRANDVAUX_IRF3_TARGETS_UP | 6.81e-05 | 13 | 166 | 3 | M5133 | |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP | CCDC18 HAT1 CHEK1 ODC1 KIF20B ZRANB3 RAD50 BRCA2 IFRD2 HASPIN SGO2 TACC3 DSCC1 | 8.50e-05 | 578 | 166 | 13 | M2368 |
| Coexpression | ZHANG_BREAST_CANCER_PROGENITORS_UP | CASP8AP2 NANP LCORL IFT81 HAT1 CHEK1 BCLAF3 ANAPC1 ERCC6L2 SGO2 PRR14L | 1.07e-04 | 434 | 166 | 11 | M15150 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | ROCK2 RNGTT HAT1 SMC5 KIF20B RLF IFRD1 MGAT5 BRCA2 BAZ1A PHF3 GCC2 ARHGAP29 DENND5A VPS13B CAP2 | 1.15e-04 | 856 | 166 | 16 | M4500 |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP | CCDC18 HAT1 CHEK1 ODC1 KIF20B ZRANB3 RAD50 BRCA2 IFRD2 HASPIN SGO2 TACC3 DSCC1 | 1.17e-04 | 597 | 166 | 13 | MM1309 |
| Coexpression | NAKAYA_B_CELL_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_UP | NUP50 MYO5A IFIT1 RAD50 UBXN2B TM9SF2 BAZ1A GLYR1 TOR1B GOLGB1 | 1.23e-04 | 367 | 166 | 10 | M41159 |
| Coexpression | ZHANG_BREAST_CANCER_PROGENITORS_UP | CASP8AP2 NANP ACTR3C IFT81 HAT1 CHEK1 BCLAF3 ANAPC1 ERCC6L2 SGO2 PRR14L | 1.41e-04 | 448 | 166 | 11 | MM1044 |
| Coexpression | BERENJENO_TRANSFORMED_BY_RHOA_UP | HSPD1 CASP8AP2 NUP50 NAA15 HAT1 CHEK1 ODC1 IFRD1 IFRD2 HASPIN TACC3 HSPA14 | 2.11e-04 | 550 | 166 | 12 | M16189 |
| Coexpression | YANG_BREAST_CANCER_ESR1_LASER_DN | 2.24e-04 | 47 | 166 | 4 | M11078 | |
| Coexpression | FEVR_CTNNB1_TARGETS_DN | CASP8AP2 NAA15 HAT1 ICE1 CHEK1 TM9SF2 BRCA2 HASPIN POLR1B KIF5B DSCC1 RAB1A | 2.29e-04 | 555 | 166 | 12 | M2343 |
| Coexpression | GSE12003_4D_VS_8D_CULTURE_BM_PROGENITOR_DN | 2.44e-04 | 137 | 166 | 6 | M406 | |
| Coexpression | GSE2706_UNSTIM_VS_8H_R848_DC_DN | 2.70e-04 | 197 | 166 | 7 | M4694 | |
| Coexpression | GSE46606_UNSTIM_VS_CD40L_IL2_IL5_DAY1_STIMULATED_BCELL_UP | 2.70e-04 | 197 | 166 | 7 | M9862 | |
| Coexpression | ERBB2_UP.V1_DN | 2.70e-04 | 197 | 166 | 7 | M2635 | |
| Coexpression | GSE7509_DC_VS_MONOCYTE_WITH_FCGRIIB_STIM_DN | 2.70e-04 | 197 | 166 | 7 | M6835 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C2_CYCLING_DC_CELL | CASP8AP2 NUP50 NAA15 RNGTT VPS4A CCDC18 HAT1 SRP68 CHEK1 SMC5 KIF20B USP5 MIS12 BRCA2 IFRD2 TOMM34 SGO2 ZNF85 NUP188 DSCC1 MCOLN2 | 2.70e-04 | 1423 | 166 | 21 | M45722 |
| Coexpression | WHITFIELD_CELL_CYCLE_G2_M | 2.78e-04 | 198 | 166 | 7 | M2077 | |
| Coexpression | GSE22886_IGM_MEMORY_BCELL_VS_BLOOD_PLASMA_CELL_UP | 2.78e-04 | 198 | 166 | 7 | M4451 | |
| Coexpression | GSE13173_UNTREATED_VS_IL12_TREATED_ACT_CD8_TCELL_DN | 2.85e-04 | 141 | 166 | 6 | M465 | |
| Coexpression | GSE29949_CD8_NEG_DC_SPLEEN_VS_DC_BRAIN_DN | 2.96e-04 | 200 | 166 | 7 | M8403 | |
| Coexpression | GSE18893_TCONV_VS_TREG_24H_CULTURE_DN | 2.96e-04 | 200 | 166 | 7 | M7289 | |
| Coexpression | GSE15930_NAIVE_VS_72H_IN_VITRO_STIM_CD8_TCELL_DN | 2.96e-04 | 200 | 166 | 7 | M3607 | |
| Coexpression | GSE17721_PAM3CSK4_VS_GADIQUIMOD_4H_BMDC_UP | 2.96e-04 | 200 | 166 | 7 | M3968 | |
| Coexpression | GSE36888_STAT5_AB_KNOCKIN_VS_WT_TCELL_IL2_TREATED_6H_DN | 2.96e-04 | 200 | 166 | 7 | M8745 | |
| Coexpression | GSE36527_CD62L_HIGH_VS_CD62L_LOW_TREG_CD69_NEG_KLRG1_NEG_UP | 2.96e-04 | 200 | 166 | 7 | M9023 | |
| Coexpression | GSE39110_DAY3_VS_DAY6_POST_IMMUNIZATION_CD8_TCELL_UP | 2.96e-04 | 200 | 166 | 7 | M9276 | |
| Coexpression | BERENJENO_TRANSFORMED_BY_RHOA_UP | HSPD1 CASP8AP2 NUP50 NAA15 HAT1 CHEK1 ODC1 IFRD1 IFRD2 HASPIN TACC3 HSPA14 | 2.97e-04 | 571 | 166 | 12 | MM1100 |
| Coexpression | LAKE_ADULT_KIDNEY_C9_THIN_ASCENDING_LIMB | 3.23e-04 | 268 | 166 | 8 | M39228 | |
| Coexpression | MURARO_PANCREAS_BETA_CELL | HSPD1 PRUNE2 MYO5A ECPAS RAD50 MTERF2 GCC2 GNA13 TOMM34 ANKRD12 KIF5B DNAH5 UTRN GOLGB1 SORL1 NIN | 3.52e-04 | 946 | 166 | 16 | M39169 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | ROCK2 CASP8AP2 SGTB ARID4B MYO5A RPAP3 KIZ CCDC18 IDI1 SMC5 KIF20B RAD50 BRCA2 BAZ1A GCC2 | 1.87e-08 | 311 | 163 | 15 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_1000 | CASP8AP2 KIZ IFT81 PECAM1 CCDC18 HAT1 CCDC172 CHEK1 ZRANB3 RAD50 BCLAF3 USP26 SYCP2 BRCA2 BAZ1A HASPIN ERCC6L2 SGO2 ANKRD12 NUP188 DSCC1 TDRD12 | 3.35e-07 | 820 | 163 | 22 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1 | ROCK2 EFCAB6 KIZ CCDC18 ECPAS SMC5 KIF20B DHX9 RLF BRCA2 BAZ1A SLCO1A2 SGO2 VAV3 KIF5B DSCC1 | 7.04e-07 | 469 | 163 | 16 | Facebase_RNAseq_e8.5_Floor Plate_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | ROCK2 CASP8AP2 SGTB RPAP3 CCDC18 ZDBF2 ECPAS SMC5 KIF20B DHX9 RLF IFRD1 BRCA2 BAZ1A PHF3 SLCO1A2 SGO2 | 7.69e-07 | 532 | 163 | 17 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 |
| CoexpressionAtlas | dev gonad_e12.5_M_GermCellTestis_Oct_top-relative-expression-ranked_1000 | ENKUR RPAP3 PECAM1 CCDC18 HAT1 CCDC172 CHEK1 KIF20B ZRANB3 RAD50 BCLAF3 USP26 SYCP2 BRCA2 HASPIN PDCD11 SGO2 POLR1B NUP188 HSPA14 TDRD12 | 8.17e-07 | 795 | 163 | 21 | gudmap_dev gonad_e12.5_M_GermCellTestis_Oct_1000 |
| CoexpressionAtlas | dev gonad_e13.5_M_GermCell_Oct_top-relative-expression-ranked_1000 | DR1 ENKUR RPAP3 KIZ PECAM1 CCDC18 HAT1 CCDC172 KIF20B ZRANB3 RAD50 BCLAF3 USP26 SYCP2 BRCA2 PDCD11 SGO2 POLR1B ANKRD12 NUP188 TDRD12 | 1.10e-06 | 810 | 163 | 21 | gudmap_dev gonad_e13.5_M_GermCell_Oct_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500_k-means-cluster#5 | CASP8AP2 CCDC18 DNAH2 ZDBF2 IDI1 KIF20B BRCA2 BAZ1A GCC2 SGO2 | 1.81e-06 | 186 | 163 | 10 | Facebase_RNAseq_e10.5_Mandibular Arch_500_K5 |
| CoexpressionAtlas | dev gonad_e12.5_M_GermCellTestis_Oct_top-relative-expression-ranked_500 | ENKUR PECAM1 CCDC18 HAT1 CCDC172 KIF20B RAD50 BCLAF3 USP26 SYCP2 BRCA2 SGO2 POLR1B TDRD12 | 1.83e-06 | 387 | 163 | 14 | gudmap_dev gonad_e12.5_M_GermCellTestis_Oct_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#3 | ROCK2 CASP8AP2 RPAP3 CCDC18 ZDBF2 IDI1 SMC5 KIF20B BRCA2 BAZ1A | 2.40e-06 | 192 | 163 | 10 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K3 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | HSPD1 ROCK2 CASP8AP2 NUP50 RNGTT SGTB ARID4B MYO5A IFT81 ACSS1 LRRC49 HAT1 ZDBF2 IDI1 SMC5 CCDC38 KIF20B ZRANB3 RAD50 BCLAF3 BRCA2 BAZ1A PHF3 GCC2 SGO2 DSCC1 | 3.64e-06 | 1257 | 163 | 26 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_1000_k-means-cluster#5 | ROCK2 SGTB ZDBF2 ECPAS SMC5 KIF20B IFRD1 BRCA2 BAZ1A SLCO1A2 | 4.13e-06 | 204 | 163 | 10 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_1000_K5 |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_k-means-cluster#2_top-relative-expression-ranked_1000 | CASP8AP2 KIZ CCDC18 HAT1 CHEK1 ZRANB3 RAD50 BCLAF3 BRCA2 HASPIN ERCC6L2 NUP188 DSCC1 | 4.54e-06 | 361 | 163 | 13 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_k2_1000 |
| CoexpressionAtlas | dev gonad_e12.5_F_GermCellOvary_Oct_top-relative-expression-ranked_1000 | NAA15 RPAP3 PECAM1 CCDC18 HAT1 CCDC172 CHEK1 KIF20B ZRANB3 RAD50 BCLAF3 USP26 SYCP2 BRCA2 HASPIN SGO2 POLR1B NUP188 DSCC1 TDRD12 | 5.26e-06 | 822 | 163 | 20 | gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | HSPD1 ROCK2 CASP8AP2 NAA15 SGTB ARID4B MYO5A RPAP3 KIZ CCDC18 HAT1 ZDBF2 IDI1 SMC5 KIF20B RAD50 IFRD1 BRCA2 BAZ1A GCC2 SLCO1A2 IFRD2 | 7.19e-06 | 989 | 163 | 22 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | ROCK2 ARID4B CCDC18 DNAH2 IDI1 ECPAS SMC5 IFIT3 KIF20B ZRANB3 RAD50 BCLAF3 MIS12 BRCA2 BAZ1A DSCC1 GOLGB1 | 7.28e-06 | 629 | 163 | 17 | Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5 |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_top-relative-expression-ranked_1000 | DR1 ATP7A MYO5A LCORL NSF SPTBN1 BBS4 CCDC172 CHEK1 NEB IFIT1 FARP2 RLF SYCP2 GNA13 ARHGAP29 SGCE PADI6 ANKRD12 | 7.56e-06 | 770 | 163 | 19 | gudmap_developingGonad_P2_ovary_1000 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_1000 | DR1 ATP7A NAA15 MYO5A LCORL SPTBN1 CCDC18 HAT1 CCDC172 CHEK1 ECPAS RLF SYCP2 BRCA2 ARHGAP29 SGCE ANKRD12 UTRN TDRD12 | 8.43e-06 | 776 | 163 | 19 | gudmap_developingGonad_e14.5_ ovary_1000 |
| CoexpressionAtlas | dev gonad_e13.5_M_GermCell_Oct_top-relative-expression-ranked_500 | ENKUR PECAM1 CCDC18 CCDC172 ZRANB3 RAD50 BCLAF3 USP26 SYCP2 BRCA2 SGO2 POLR1B TDRD12 | 1.22e-05 | 396 | 163 | 13 | gudmap_dev gonad_e13.5_M_GermCell_Oct_500 |
| CoexpressionAtlas | dev gonad_e11.5_F_PrimGermCell_Oct_top-relative-expression-ranked_1000 | ENKUR PECAM1 CCDC18 HAT1 CCDC172 CHEK1 KIF20B ZRANB3 MYO5C RAD50 BCLAF3 USP26 BRCA2 PDCD11 SGO2 POLR1B NUP188 HSPA14 TDRD12 | 1.27e-05 | 799 | 163 | 19 | gudmap_dev gonad_e11.5_F_PrimGermCell_Oct_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | HSPD1 ROCK2 CASP8AP2 NUP50 RNGTT SGTB ARID4B MYO5A IFT81 ACSS1 LRRC49 HAT1 ZDBF2 IDI1 SMC5 CCDC38 KIF20B ZRANB3 RAD50 BCLAF3 BRCA2 BAZ1A PHF3 GCC2 PITX2 SGO2 DSCC1 | 1.76e-05 | 1459 | 163 | 27 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#3 | ROCK2 ARID4B CCDC18 IDI1 ECPAS SMC5 KIF20B RAD50 BCLAF3 BRCA2 BAZ1A GCC2 GOLGB1 | 3.04e-05 | 432 | 163 | 13 | Facebase_RNAseq_e10.5_Maxillary Arch_1000_K3 |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_1000 | DR1 ATP7A NAA15 MYO5A LCORL SPTBN1 CCDC172 CHEK1 NEB MAP10 RLF SYCP2 GNA13 ARHGAP29 SGCE ANKRD12 UTRN TDRD12 | 3.13e-05 | 778 | 163 | 18 | gudmap_developingGonad_e18.5_ovary_1000 |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_k-means-cluster#3_top-relative-expression-ranked_500 | 3.27e-05 | 79 | 163 | 6 | gudmap_developingGonad_P2_ovary_500_k3 | |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_top-relative-expression-ranked_500 | ATP7A MYO5A LCORL SPTBN1 BBS4 CCDC172 NEB RLF SYCP2 ARHGAP29 PADI6 ANKRD12 | 3.80e-05 | 379 | 163 | 12 | gudmap_developingGonad_P2_ovary_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | ROCK2 RALGAPA1 CASP8AP2 SGTB MYO5A RPAP3 KIZ ZDBF2 IDI1 SMC5 KIF20B RAD50 IFRD1 BRCA2 BAZ1A ERCC6L2 PRR14L CAP2 | 7.31e-05 | 831 | 163 | 18 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 |
| CoexpressionAtlas | dev gonad_e12.5_F_GermCellOvary_Oct_top-relative-expression-ranked_500 | PECAM1 CCDC18 HAT1 CCDC172 CHEK1 BCLAF3 USP26 SYCP2 BRCA2 SGO2 POLR1B TDRD12 | 7.35e-05 | 406 | 163 | 12 | gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_500 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500_K1 | HSPD1 ROCK2 CASP8AP2 SGTB ARID4B IFT81 LRRC49 ZDBF2 ODC1 IDI1 SMC5 CCDC38 KIF20B DHX9 RAD50 BRCA2 BAZ1A GCC2 ASXL3 SGO2 KIF5B DSCC1 ZNF654 | 7.77e-05 | 1241 | 163 | 23 | facebase_RNAseq_e10.5_MandArch_2500_K1 |
| CoexpressionAtlas | dev gonad_e11.5_M_PrimGermCell_Oct_top-relative-expression-ranked_1000 | ENKUR PECAM1 CCDC18 HAT1 CHEK1 KIF20B ZRANB3 RAD50 BCLAF3 USP26 SYCP2 BRCA2 SGO2 POLR1B NUP188 HSPA14 TDRD12 | 1.10e-04 | 781 | 163 | 17 | gudmap_dev gonad_e11.5_M_PrimGermCell_Oct_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500 | CASP8AP2 CCDC18 DNAH2 TENT5C ZDBF2 IDI1 KIF20B BRCA2 BAZ1A GCC2 ASXL3 SGO2 FAM149A | 1.14e-04 | 492 | 163 | 13 | Facebase_RNAseq_e10.5_Mandibular Arch_500 |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_200 | 1.20e-04 | 143 | 163 | 7 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_200 | |
| CoexpressionAtlas | dev gonad_e12.5_F_GermCellOvary_Oct_top-relative-expression-ranked_200 | 1.43e-04 | 147 | 163 | 7 | gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_200 | |
| CoexpressionAtlas | dev gonad_e11.5_M_PrimGermCell_Oct_top-relative-expression-ranked_500 | ENKUR PECAM1 CCDC18 KIF20B ZRANB3 BCLAF3 USP26 BRCA2 SGO2 POLR1B TDRD12 | 1.61e-04 | 376 | 163 | 11 | gudmap_dev gonad_e11.5_M_PrimGermCell_Oct_500 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_500 | ATP7A MYO5A LCORL CCDC18 CCDC172 CHEK1 RLF SYCP2 ARHGAP29 ANKRD12 TDRD12 | 1.85e-04 | 382 | 163 | 11 | gudmap_developingGonad_e14.5_ ovary_500 |
| CoexpressionAtlas | dev gonad_e11.5_F_PrimGermCell_Oct_k-means-cluster#3_top-relative-expression-ranked_1000 | ENKUR HAT1 KIF20B ZRANB3 RAD50 USP26 PDCD11 SGO2 POLR1B NUP188 HSPA14 TDRD12 | 2.50e-04 | 463 | 163 | 12 | gudmap_dev gonad_e11.5_F_PrimGermCell_Oct_k3_1000 |
| CoexpressionAtlas | alpha beta T cells, preT.DN3-4.Th, Lin-/lo CD25int CD44- CD28+, Thymus, avg-3 | HSPD1 RPAP3 CCDC18 HAT1 CHEK1 KIF20B ZRANB3 BRCA2 SGO2 TACC3 DSCC1 | 2.57e-04 | 397 | 163 | 11 | GSM791143_500 |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_k-means-cluster#4_top-relative-expression-ranked_1000 | 3.24e-04 | 168 | 163 | 7 | gudmap_developingGonad_P2_ovary_1000_k4 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500 | HSPD1 ROCK2 CASP8AP2 SGTB ARID4B IFT81 LRRC49 ZDBF2 ODC1 IDI1 SMC5 CCDC38 KIF20B DHX9 RAD50 BRCA2 BAZ1A GCC2 ASXL3 PITX2 SGO2 KIF5B DSCC1 ZNF654 | 3.56e-04 | 1468 | 163 | 24 | facebase_RNAseq_e10.5_MandArch_2500 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000 | MGAM ATP7A NAA15 LCORL SPTBN1 TENT5C CHEK1 CREB3L1 RLF GNA13 ASXL3 SGCE TOR1B ANKRD12 PCDH10 UTRN | 3.95e-04 | 790 | 163 | 16 | gudmap_developingGonad_e16.5_epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_1000 | ATP7A NAA15 MYO5A LCORL SPTBN1 CCDC172 MAP10 RLF SYCP2 GNA13 ARHGAP29 SGCE ANKRD12 ALB POLN UTRN | 4.23e-04 | 795 | 163 | 16 | gudmap_developingGonad_e16.5_ovary_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#3 | 4.28e-04 | 291 | 163 | 9 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#4 | 5.08e-04 | 298 | 163 | 9 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_1000_K4 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MaxArch_2500_K3 | ROCK2 CASP8AP2 SGTB ARID4B VPS4A LRRC49 HAT1 IDI1 SMC5 CCDC38 KIF20B RAD50 BCLAF3 ULK3 NTN4 BRCA2 BAZ1A GCC2 SGO2 ANKRD12 ZNF654 | 6.17e-04 | 1252 | 163 | 21 | facebase_RNAseq_e10.5_MaxArch_2500_K3 |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_500 | CASP8AP2 PECAM1 CCDC18 CCDC172 CHEK1 BCLAF3 USP26 SYCP2 BRCA2 TDRD12 | 8.07e-04 | 385 | 163 | 10 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_500 |
| CoexpressionAtlas | dev gonad_e11.5_M_PrimGermCell_Oct_k-means-cluster#3_top-relative-expression-ranked_500 | 8.08e-04 | 142 | 163 | 6 | gudmap_dev gonad_e11.5_M_PrimGermCell_Oct_k3_500 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 | CASP8AP2 NUP50 RNGTT SGTB ARID4B MYO5A NSF IFT81 ACSS1 HAT1 ZDBF2 SMC5 CCDC38 KIF20B RAD50 NTN4 BRCA2 BAZ1A PHF3 GCC2 SGCE PRRG3 | 8.11e-04 | 1370 | 163 | 22 | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 |
| CoexpressionAtlas | dev gonad_e11.5_M_PrimGermCell_Oct_k-means-cluster#2_top-relative-expression-ranked_1000 | 8.77e-04 | 258 | 163 | 8 | gudmap_dev gonad_e11.5_M_PrimGermCell_Oct_k2_1000 | |
| CoexpressionAtlas | dev gonad_e12.5_M_GermCellTestis_Oct_k-means-cluster#2_top-relative-expression-ranked_500 | 9.01e-04 | 56 | 163 | 4 | gudmap_dev gonad_e12.5_M_GermCellTestis_Oct_k2_500 | |
| CoexpressionAtlas | alpha beta T cells, NKT.44+NK1.1-.Th, aGC CD1d tet CD3 CD44, Thymus, avg-3 | 9.26e-04 | 392 | 163 | 10 | GSM538335_500 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_k-means-cluster#2_top-relative-expression-ranked_1000 | 9.58e-04 | 98 | 163 | 5 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_k2_1000 | |
| ToppCell | (04)_Interm._basal>secr.-(2)_GFP_FOXI1|(04)_Interm._basal>secr. / shred by cell type by condition | ROCK2 NAA15 ARID4B YWHAH RAD50 BAZ1A GCC2 ANKRD12 TRIM38 GOLGB1 SORL1 | 2.83e-10 | 199 | 168 | 11 | 53ca3861f9e00dab3f3fbefb0837857ee39ab084 |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | HSPD1 RALGAPA1 ARID4B DGKH PARP14 RLF IFRD1 ANKRD12 UTRN GOLGB1 | 2.71e-09 | 188 | 168 | 10 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | NAA15 CCDC18 KIF20B RAD50 BAZ1A GCC2 ANKRD12 UTRN TRIM38 GOLGB1 | 4.46e-09 | 198 | 168 | 10 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | NAA15 ARID4B RAD50 BAZ1A PHF3 GCC2 ANKRD12 DNAH5 TRIM38 GOLGB1 | 4.68e-09 | 199 | 168 | 10 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce |
| ToppCell | droplet-Lung-nan-3m-Lymphocytic-Proliferating_NK|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.48e-09 | 158 | 168 | 9 | ee8ce3cd202807df692b28bb1a81827d49d73862 | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 5.36e-08 | 193 | 168 | 9 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | (00)_Basal-(2)_GFP_FOXI1|(00)_Basal / shred by cell type by condition | 6.97e-08 | 199 | 168 | 9 | 19674e1eaeb51e4196d847cb62aa437c852951d3 | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 6.97e-08 | 199 | 168 | 9 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.11e-07 | 184 | 168 | 8 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.11e-07 | 184 | 168 | 8 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.11e-07 | 184 | 168 | 8 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 7.05e-07 | 192 | 168 | 8 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | moderate-Epithelial-FOXN4+|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 7.63e-07 | 194 | 168 | 8 | dff3fb10372053951d41e0ccd41aac3ece6009bd | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 7.93e-07 | 195 | 168 | 8 | 633c7668fe365f7b0f7851cdc442d5dd89c454e2 | |
| ToppCell | COVID-19_Moderate|World / disease group, cell group and cell class | 9.24e-07 | 199 | 168 | 8 | 952fac67588ad5676f5939e3c7f8bac803c27064 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 9.59e-07 | 200 | 168 | 8 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | LPS_only-Endothelial-Endothelial-Activated_Alv_Cap|LPS_only / Treatment groups by lineage, cell group, cell type | 9.59e-07 | 200 | 168 | 8 | edb64556b3fefe3144f73b6efe23b9ffd34091d2 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 9.59e-07 | 200 | 168 | 8 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 9.59e-07 | 200 | 168 | 8 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | (08)_Brush+PNEC-(2)_GFP_FOXI1|(08)_Brush+PNEC / shred by cell type by condition | 9.59e-07 | 138 | 168 | 7 | 817e3f639604ea95adae01e8685ffaa2e0aff7a8 | |
| ToppCell | droplet-Heart-nan-24m-Hematologic-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.42e-06 | 167 | 168 | 7 | bad33497ceeab968a7eb8a48b921c6f936390743 | |
| ToppCell | Club-club-3|World / Class top | 4.16e-06 | 172 | 168 | 7 | 34fbb82a2ec77dd183cf26b38edeb7e936b707bc | |
| ToppCell | droplet-Mammary_Gland-nan-3m-Endothelial-nan|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.32e-06 | 173 | 168 | 7 | fbc8ed566ea36c39c258dd6b3823c82f5d6eb17f | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Endothelial|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.02e-06 | 177 | 168 | 7 | ca5a30b3e7bcfdd8de01ceaf7449735b5cd503af | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Endothelial-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.02e-06 | 177 | 168 | 7 | f471f7747d6e8db7546899019af9508f48a14f89 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Endothelial-endothelial_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.02e-06 | 177 | 168 | 7 | cd0684b876c2a7d5fe7e2773e8e25bb61ecbc795 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.21e-06 | 178 | 168 | 7 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-FOXM1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.61e-06 | 180 | 168 | 7 | 334e2b1f6eb7d4ece20b1c7b02107863f913237f | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Lymphocytic-T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.03e-06 | 182 | 168 | 7 | 3948422707d6d5e021bcd7158e2eb69143613f62 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Lymphocytic-Proliferating_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.03e-06 | 182 | 168 | 7 | fe46819c153a81911864473badc794f243705f98 | |
| ToppCell | TCGA-Liver-Primary_Tumor-Hepatocellular_Carcinoma-Hepatocellular_Carcinoma-5|TCGA-Liver / Sample_Type by Project: Shred V9 | 6.25e-06 | 183 | 168 | 7 | f604a8b62c7088fad8365dbf8d910fc980bd3ba8 | |
| ToppCell | Calu_3-infected|Calu_3 / Cell line, Condition and Strain | 6.25e-06 | 183 | 168 | 7 | 8f7f5000645f24f20a8d7700c4df1f8953a1780b | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-B_cell-B_cells-B_cells_L.1.5.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.71e-06 | 185 | 168 | 7 | e913c64f9b4873443d88dce270f0b7b6d1b4cbce | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 6.95e-06 | 186 | 168 | 7 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.26e-06 | 191 | 168 | 7 | 1ecd9849d14d5ebf3daf610e83fb50820cafd3ed | |
| ToppCell | Mild-T/NK_proliferative|World / Disease group and Cell class | 8.26e-06 | 191 | 168 | 7 | 9dba5526fd5ea8065ad305feb2ee562335f887c6 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Activated_Alv_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.26e-06 | 191 | 168 | 7 | a7b18bcf27c38ad2353c239ecb309c80f3ef3359 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 8.84e-06 | 193 | 168 | 7 | 4b9fa2a4424f8abe63fa7bee78db93dda04ab15f | |
| ToppCell | COVID-19_Mild|World / Disease condition and Cell class | 8.84e-06 | 193 | 168 | 7 | 7256a5a491536c525b31ae96d47ab5c6303cb73a | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 9.46e-06 | 195 | 168 | 7 | 926eb3fc5d028be936885bea0654a77db3107234 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-Stress_sig-F_2|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.78e-06 | 196 | 168 | 7 | ea8eceacc5d5e1a22b77c31e7c45985dc7bb15de | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Proliferating-Cycling_Progenitors|3.5_mon / Sample Type, Dataset, Time_group, and Cell type. | 9.78e-06 | 196 | 168 | 7 | 5905f0e3061a6b98b7a33d64c782c3dda2cd51ef | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD4+_T-Treg-Treg_2|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.01e-05 | 130 | 168 | 6 | 0f9d3e6297f48ae14d24ac997d8d3a94f337d4d4 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD4+_T-Treg-Treg_2|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.01e-05 | 130 | 168 | 6 | fc68a648161dd314d9ee6612fd039cb12171b8c6 | |
| ToppCell | COVID-19_Mild|World / Disease group, lineage and cell class | 1.01e-05 | 197 | 168 | 7 | 5c33454b10023decd2f5ccda9229b6512659711e | |
| ToppCell | B_cells-Memory_B_cells|B_cells / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 1.01e-05 | 197 | 168 | 7 | cdd1dbdaf257b0864c6dc8c1cbed6e9b68e114b7 | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.04e-05 | 198 | 168 | 7 | 44417089b62056269cac38d3134ff209c05b7007 | |
| ToppCell | droplet-Thymus-nan-18m-Lymphocytic-DN_to_DP_transition,_dividing_(more_DN)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-05 | 198 | 168 | 7 | c78ff8fc71dfcba1ac0c373bc90ea7b87c5699a4 | |
| ToppCell | COVID-19-Epithelial-AT2,_AT1_cells|COVID-19 / Condition, Lineage and Cell class | 1.04e-05 | 198 | 168 | 7 | 7e6f089e71e70190ff8486341ab06719d7741467 | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.04e-05 | 198 | 168 | 7 | 28ef3fc4c17dcb765537b75917f7db78baa522db | |
| ToppCell | (11)_FOXN4+|World / shred by cell type by condition | 1.04e-05 | 198 | 168 | 7 | 516b1acdf997dd8debc3dca066519366e507b414 | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.08e-05 | 199 | 168 | 7 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | (10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition | 1.08e-05 | 199 | 168 | 7 | 61b1ed2db71b96157b92b7535d1955a4033098da | |
| ToppCell | ASK452-Epithelial-Type_1|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.08e-05 | 199 | 168 | 7 | 48cafe44951908d03f3c6f3e185e9cbb86fb5b3b | |
| ToppCell | (05)_Secretory-(2)_GFP_FOXI1|(05)_Secretory / shred by cell type by condition | 1.08e-05 | 199 | 168 | 7 | d72d87e1e530ed894c0ad5e7b5b2b1d6b59fa098 | |
| ToppCell | (01)_IL1RL1+-(2)_GFP_FOXI1|(01)_IL1RL1+ / shred by cell type by condition | 1.08e-05 | 199 | 168 | 7 | a2f7d0cabf35b80fe239fae34a77bf9344d5d743 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.11e-05 | 200 | 168 | 7 | 72ea9882a8ed26fa1534aeb6ba0d1897dccc20c5 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.11e-05 | 200 | 168 | 7 | bcd1cc96197929d6011903803b6f4ccdcf52b4ce | |
| ToppCell | LPS_only-Endothelial-Endothelial-Activated_Gen_Cap|LPS_only / Treatment groups by lineage, cell group, cell type | 1.11e-05 | 200 | 168 | 7 | 6f531a418ff25b59a543800cf4bce7b72404ce08 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Activated_Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.11e-05 | 200 | 168 | 7 | 2d07237022b409c4fac6fcf99b68c8affb3007cd | |
| ToppCell | LPS_IL1RA-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.11e-05 | 200 | 168 | 7 | 5c092b2ecc081b5d04476c56333c338cd89ab984 | |
| ToppCell | Control_saline-Endothelial-Endothelial|Control_saline / Treatment groups by lineage, cell group, cell type | 1.11e-05 | 200 | 168 | 7 | e77eba6172cabf85b8028638ed35299f2f079cd8 | |
| ToppCell | critical-Epithelial-FOXN4+|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.11e-05 | 200 | 168 | 7 | f39db4250ce220a3eb58edee3f7fc3671701d46f | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Proliferating|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 1.11e-05 | 200 | 168 | 7 | cea58274efbe7f9e3c3ef9fbb768ebfb917e21d9 | |
| ToppCell | Control_saline-Endothelial-Endothelial-Activated_Alv_Cap|Control_saline / Treatment groups by lineage, cell group, cell type | 1.11e-05 | 200 | 168 | 7 | be55cef682ba87250dad97689332c8820b3a7420 | |
| ToppCell | Control_saline-Endothelial-Endothelial-Alv_Cap|Control_saline / Treatment groups by lineage, cell group, cell type | 1.11e-05 | 200 | 168 | 7 | abf4ba5fcb54cdeada0da1a8b956a30aa47679e4 | |
| ToppCell | Control_saline-Endothelial|Control_saline / Treatment groups by lineage, cell group, cell type | 1.11e-05 | 200 | 168 | 7 | 3372c488a39fe812fa94e4f0564594186fea3db5 | |
| ToppCell | COVID-19-COVID-19_Mild|COVID-19 / Disease, condition lineage and cell class | 1.11e-05 | 200 | 168 | 7 | 62c25042086f1afd1102e0720e933c2e476468fd | |
| ToppCell | LPS-IL1RA-Endothelial-Epi-like-Alv_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.42e-05 | 138 | 168 | 6 | 5f8ac8f67e34a7cf560099208e6884102532391e | |
| ToppCell | PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD8_T-CD8_T_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.64e-05 | 154 | 168 | 6 | f78b01c19afcbab6319f61e4d6023ecb3d510d24 | |
| ToppCell | Globus_pallidus-Macroglia-POLYDENDROCYTE-P5-P5_1|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 3.38e-05 | 161 | 168 | 6 | 0dd1401b4c990d49fccb702a9f9867590a58e203 | |
| ToppCell | Globus_pallidus-Macroglia-POLYDENDROCYTE-P5-P5_1-Mitotic.MkI67_(Mitotic.MkI67)-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 3.38e-05 | 161 | 168 | 6 | b6a31c033edc74f23a20aab1f18e80cc83ffee4c | |
| ToppCell | Globus_pallidus-Macroglia-POLYDENDROCYTE-P5|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 3.38e-05 | 161 | 168 | 6 | efb811dda4d73107983a5f68302bdcf4f408d5b4 | |
| ToppCell | Globus_pallidus-Macroglia-POLYDENDROCYTE-P5-P5_1-Mitotic.MkI67_(Mitotic.MkI67)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 3.38e-05 | 161 | 168 | 6 | 28d5dbd20c9f8e0069f172d552997a044790e1a7 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.75e-05 | 164 | 168 | 6 | 382e42701779d12a7948690b3be72d06dd75c8b4 | |
| ToppCell | droplet-Skin-nan-18m-Epithelial-stem_cell_of_epidermis|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.88e-05 | 165 | 168 | 6 | 96f0d8bc9b13e23f757e6bb98cd7dc061a8a9564 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum_-18m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.01e-05 | 166 | 168 | 6 | 4ab1959c526c2fd83077fc03e4de207f34841a19 | |
| ToppCell | Substantia_nigra-Macroglia-OLIGODENDROCYTE-O2-Tnr-Oligodendrocyte.Tnr.Rps24_(Rps24)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 4.06e-05 | 101 | 168 | 5 | c075aa59acf333b05b6533b8172dc0c5c31b6ed3 | |
| ToppCell | Substantia_nigra-Macroglia-OLIGODENDROCYTE-O2-Tnr-Oligodendrocyte.Tnr.Rps24_(Rps24)-|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 4.06e-05 | 101 | 168 | 5 | be1c3034c2ebe64b7dd7a9b31ea43336ea1eeb73 | |
| ToppCell | Substantia_nigra-Macroglia-OLIGODENDROCYTE-O2-Tnr|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 4.06e-05 | 101 | 168 | 5 | 8ce6ebda05081dbd7db891e5da8af9cc7d4beacb | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-FOXM1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.44e-05 | 169 | 168 | 6 | e0607af8ae8609d43e26ff2a2cab92650bfcd5b7 | |
| ToppCell | Dividing_Macrophages-IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 4.44e-05 | 169 | 168 | 6 | bc859a103cad567caf50c3c3882d2d2017807c73 | |
| ToppCell | PND10-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.58e-05 | 170 | 168 | 6 | 4ce81608111b9ee7cb974dad2c182f38db3dcd79 | |
| ToppCell | PND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_G2M|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.58e-05 | 170 | 168 | 6 | e08a6c5ac34c456da8c7318f104e06fca585be1f | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-PMP-PMP_G2M|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.89e-05 | 172 | 168 | 6 | c06ca5d075937747952ed915c9db39a9f62072f9 | |
| ToppCell | (07)_Ionocytes-(2)_GFP_FOXI1|(07)_Ionocytes / shred by cell type by condition | 4.89e-05 | 172 | 168 | 6 | 5776b638b845d054f6e884e7df0412477f48517d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell_prolif|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.05e-05 | 173 | 168 | 6 | f193c63cc536d891c9d23043765e320252bb6e65 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-PMP|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.39e-05 | 175 | 168 | 6 | a154b28b0b2180652d51d4c7d804b3b81b35899e | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-classical_monocyte_proliferating-classical_monocyte_proliferating_l2|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.56e-05 | 176 | 168 | 6 | 1510cdfcfb46ce1196a1220c07fb5f3986c81b78 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Endothelial-blood_vessel_EC-Mature_venous_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.92e-05 | 178 | 168 | 6 | ea10117026021c959ffc871fc377cdb3e161d264 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l2-17-52|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.11e-05 | 179 | 168 | 6 | af03705a783e77f75c44fdfa793cfdccbf9dd91c | |
| ToppCell | MS-Treg-naive_CD4|MS / Condition, Cell_class and T cell subcluster | 6.30e-05 | 180 | 168 | 6 | 7ca083616926d98420fa11a6e5ebc981623f79ac | |
| ToppCell | PND01-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.30e-05 | 180 | 168 | 6 | b35a8c6169f4b548b912af005e92ae7c6596f376 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-B_cell-B_cells-B_cells_L.1.5.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.49e-05 | 181 | 168 | 6 | d66838fca0429cad2079cd8d92a5cd33eb0d3522 | |
| ToppCell | droplet-Lung-LUNG-30m-Lymphocytic-Proliferating_NK|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.69e-05 | 182 | 168 | 6 | 0370b395ceb9d4d66f80cf60dd8c28ac60af5c7b | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.69e-05 | 182 | 168 | 6 | e78ba2c5cae480c16a596ce7c3bf2d480becacf4 | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.69e-05 | 182 | 168 | 6 | 1710eab3037a87609d21838be2d2d29c3bc36651 | |
| ToppCell | 367C-Lymphocytic-NK_cells-Proliferating_NK_cell|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 6.90e-05 | 183 | 168 | 6 | a716b446c2bf5aa294b8f580aa845098fae76354 | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.11e-05 | 184 | 168 | 6 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | Control-Neu_4|World / 5 Neutrophil clusters in COVID-19 patients | 7.11e-05 | 184 | 168 | 6 | ce7f044956613118ee2e9fb6af2455c3166cb414 | |
| Drug | SnET2 | 6.17e-06 | 17 | 167 | 4 | CID006918321 | |
| Drug | Magnetite Nanoparticles | HSPD1 CASP8AP2 RPL37A ATP7A CHEK1 ODC1 IDI1 IFIT1 IFIT3 KIF20B DHX9 RAD50 UBXN2B BRCA2 BAZ1A ANAPC1 PHF3 GNA13 VAV3 ANKRD12 KIF5B DSCC1 UTRN MCOLN2 SORL1 | 1.07e-05 | 1310 | 167 | 25 | ctd:D058185 |
| Drug | Fluvoxamine maleate [61718-82-9]; Down 200; 9.2uM; MCF7; HT_HG-U133A | 1.17e-05 | 190 | 167 | 9 | 4114_DN | |
| Drug | AC1NPJ0T | 1.23e-05 | 20 | 167 | 4 | CID005159168 | |
| Drug | troglitazone; Down 200; 10uM; MCF7; HT_HG-U133A_EA | 1.63e-05 | 198 | 167 | 9 | 1070_DN | |
| Drug | 2-propylpentanoic acid; Up 200; 50uM; MCF7; HT_HG-U133A_EA | 1.63e-05 | 198 | 167 | 9 | 1002_UP | |
| Drug | KRM-1648 | 1.84e-05 | 22 | 167 | 4 | CID006540558 | |
| Drug | Gd-DTPA | 2.65e-05 | 24 | 167 | 4 | CID000055466 | |
| Drug | cuminaldehyde | 3.15e-05 | 9 | 167 | 3 | CID000000326 | |
| Drug | magnesium | HSPD1 MGAM RPL37A NANP MYO5A NSF VPS4A ACSS1 SPTBN1 DGKH PFDN5 GRIN2A ODC1 IDI1 MYO5C GCC2 SLCO1A2 HASPIN POLR1B ALB DENND5A POLN DNAH5 CAP2 | 3.82e-05 | 1325 | 167 | 24 | CID000000888 |
| Drug | imazaquin | 4.48e-05 | 10 | 167 | 3 | CID000054739 | |
| Drug | melanin | 4.76e-05 | 227 | 167 | 9 | CID006325610 | |
| Drug | Succimer | CASP8AP2 RPL37A ATP7A CHEK1 ODC1 IDI1 IFIT1 IFIT3 KIF20B DHX9 UBXN2B BRCA2 BAZ1A ANAPC1 PHF3 GNA13 VAV3 ANKRD12 KIF5B DSCC1 UTRN MCOLN2 SORL1 | 5.25e-05 | 1264 | 167 | 23 | ctd:D004113 |
| Drug | N-adamant-1-yl-N'-(2-iodophenyl)guanidinium | 5.35e-05 | 2 | 167 | 2 | CID000064600 | |
| Drug | CG-PAC | 5.35e-05 | 2 | 167 | 2 | CID000195089 | |
| Drug | triostin C | 5.35e-05 | 2 | 167 | 2 | CID000159284 | |
| Drug | 2-methyl-3,4'-bipyridin-6(1H)-one | 5.35e-05 | 2 | 167 | 2 | CID000133351 | |
| Drug | MEGA-11 | 5.35e-05 | 2 | 167 | 2 | CID000147863 | |
| Drug | Rb 6162 | 5.35e-05 | 2 | 167 | 2 | CID000196742 | |
| Drug | NSC321251 | 5.35e-05 | 2 | 167 | 2 | CID000113639 | |
| Drug | PLP-HSA | 5.35e-05 | 2 | 167 | 2 | CID005289173 | |
| Drug | N4-Benzoyl-2',3'-dideoxycytidine | 5.35e-05 | 2 | 167 | 2 | CID000357106 | |
| Drug | ethyl phenyl selenone | 5.35e-05 | 2 | 167 | 2 | CID000130447 | |
| Drug | 1-bromoestradiol | 5.35e-05 | 2 | 167 | 2 | CID000067381 | |
| Drug | 1-fluoroestradiol | 5.35e-05 | 2 | 167 | 2 | CID000067382 | |
| Drug | N-(4-methylphenyl)acetohydroxamic acid | 5.35e-05 | 2 | 167 | 2 | CID000033858 | |
| Drug | difluorotriphenylphosphorane | 5.35e-05 | 2 | 167 | 2 | CID000193320 | |
| Drug | (2S)-2-aminobutanal | 5.35e-05 | 2 | 167 | 2 | CID000446769 | |
| Drug | AC1OCEMJ | 5.35e-05 | 2 | 167 | 2 | CID006917763 | |
| Drug | Mnbq | 5.35e-05 | 2 | 167 | 2 | CID000131309 | |
| Drug | Quercetine dihydrate [6151-25-3]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 5.68e-05 | 180 | 167 | 8 | 2859_DN | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; PC3; HT_HG-U133A | 5.68e-05 | 180 | 167 | 8 | 4541_DN | |
| Drug | Daunorubicin hydrochloride [23541-50-6]; Down 200; 7uM; MCF7; HT_HG-U133A | 8.30e-05 | 190 | 167 | 8 | 4983_DN | |
| Drug | Sanguinarine [2447-54-3]; Down 200; 12uM; MCF7; HT_HG-U133A | 8.61e-05 | 191 | 167 | 8 | 4168_DN | |
| Drug | pyrophosphate | MGAM RNGTT MYO5A NSF ACSS1 TRPM2 SRP68 IDI1 MYO5C FARP2 ANAPC1 SLCO1A2 POLR1B POLN RAB1A | 9.96e-05 | 654 | 167 | 15 | CID000001023 |
| Drug | Levonordefrin [829-74-3]; Up 200; 21.8uM; MCF7; HT_HG-U133A | 1.03e-04 | 196 | 167 | 8 | 7208_UP | |
| Drug | PAMBA | 1.05e-04 | 13 | 167 | 3 | CID000065526 | |
| Drug | Nitrofurantoin [67-20-9]; Down 200; 16.8uM; HL60; HT_HG-U133A | 1.07e-04 | 197 | 167 | 8 | 2341_DN | |
| Drug | Convolamine hydrochloride [500-56-1]; Up 200; 11.8uM; PC3; HT_HG-U133A | 1.11e-04 | 198 | 167 | 8 | 5876_UP | |
| Drug | mantATP | 1.22e-04 | 35 | 167 | 4 | CID000123756 | |
| Drug | AC1L1AVB | 1.60e-04 | 3 | 167 | 2 | CID000001164 | |
| Drug | Boc-phenylalanine | 1.60e-04 | 3 | 167 | 2 | CID000077857 | |
| Drug | Gymnogrammene | 1.60e-04 | 3 | 167 | 2 | CID006438580 | |
| Drug | CGS 14796C | 1.60e-04 | 3 | 167 | 2 | CID000196683 | |
| Drug | NSC-695576 | 1.60e-04 | 3 | 167 | 2 | CID000393518 | |
| Drug | NTCDA | 1.60e-04 | 3 | 167 | 2 | CID000006678 | |
| Drug | 3,3-Dimethyl-1,2-butanediol | 1.60e-04 | 3 | 167 | 2 | CID000101077 | |
| Drug | acetomycin | 1.60e-04 | 3 | 167 | 2 | CID000100162 | |
| Drug | AC1L4F9J | 1.60e-04 | 3 | 167 | 2 | CID000155940 | |
| Drug | deoxyarteether | 1.60e-04 | 3 | 167 | 2 | CID000538358 | |
| Drug | 6-Odbcn | 1.60e-04 | 3 | 167 | 2 | CID000131989 | |
| Drug | cytosine dichloride cuprate | 1.60e-04 | 3 | 167 | 2 | CID003082432 | |
| Drug | methoxycarbonylcholine | 1.60e-04 | 3 | 167 | 2 | CID000129824 | |
| Drug | Acetyl benzyl disulfide | 1.60e-04 | 3 | 167 | 2 | CID000193413 | |
| Drug | 6-DMBQ | 1.60e-04 | 3 | 167 | 2 | CID000193384 | |
| Drug | AC1L30LS | 1.60e-04 | 3 | 167 | 2 | CID000132226 | |
| Drug | 5-APA | 1.60e-04 | 3 | 167 | 2 | CID000130129 | |
| Drug | 4-(3-chlorophenyl)thiosemicarbazide | 1.60e-04 | 3 | 167 | 2 | CID000707050 | |
| Drug | N2 76 | 1.60e-04 | 3 | 167 | 2 | CID000192216 | |
| Disease | disease recurrence, response to allogeneic hematopoietic stem cell transplant | 3.03e-05 | 2 | 163 | 2 | EFO_0004952, EFO_0007044 | |
| Disease | Endometrial Stromal Sarcoma | 3.00e-04 | 5 | 163 | 2 | C0206630 | |
| Disease | Clear cell sarcoma of kidney | 4.48e-04 | 6 | 163 | 2 | C0334488 | |
| Disease | cell surface glycoprotein CD200 receptor 1 measurement | 4.48e-04 | 6 | 163 | 2 | EFO_0020253 | |
| Disease | Breast Cancer, Familial | 6.02e-04 | 30 | 163 | 3 | C0346153 | |
| Disease | lupus nephritis | 7.99e-04 | 33 | 163 | 3 | EFO_0005761 | |
| Disease | spinal muscular atrophy (implicated_via_orthology) | 1.06e-03 | 9 | 163 | 2 | DOID:12377 (implicated_via_orthology) | |
| Disease | quality of life during menstruation measurement, dysmenorrheic pain measurement | 1.61e-03 | 11 | 163 | 2 | EFO_0007889, EFO_0009366 | |
| Disease | HIV-1 infection | 2.17e-03 | 98 | 163 | 4 | EFO_0000180 | |
| Disease | urinary bladder carcinoma | 2.25e-03 | 47 | 163 | 3 | MONDO_0004986 | |
| Disease | squamous cell lung carcinoma | 2.28e-03 | 165 | 163 | 5 | EFO_0000708 | |
| Disease | ocular hypertension, response to triamcinolone acetonide | 2.53e-03 | 49 | 163 | 3 | EFO_0006954, EFO_1001069 | |
| Disease | Hereditary Breast and Ovarian Cancer Syndrome | 2.64e-03 | 14 | 163 | 2 | C0677776 | |
| Disease | Influenza | 3.00e-03 | 52 | 163 | 3 | C0021400 | |
| Disease | Inherited oocyte maturation defect | 3.46e-03 | 16 | 163 | 2 | cv:CN238505 | |
| Disease | eosinophil count | ADAMTS19 DR1 CAMK2G SPTBN1 CCDC18 DGKH CLSTN1 CD200R1 RAD50 FARP2 SLAMF6 MGAT5 TM9SF2 ANAPC1 PLEKHO2 POLR1B VAV3 | 3.69e-03 | 1488 | 163 | 17 | EFO_0004842 |
| Disease | hippocampal atrophy | 3.70e-03 | 56 | 163 | 3 | EFO_0005039 | |
| Disease | urolithiasis | 5.16e-03 | 63 | 163 | 3 | MONDO_0024647 | |
| Disease | cortisol measurement | 5.40e-03 | 20 | 163 | 2 | EFO_0005843 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KENNSVEYKKSKADC | 196 | Q9BXU7 | |
| VVCVDYISLDKKKAL | 176 | Q4LE39 | |
| KDYEACKAVIKEQLQ | 46 | Q96RK4 | |
| IAEILSVYQKCKDKQ | 671 | Q9NUB1 | |
| KKEYVECLEKKVETF | 311 | Q96BA8 | |
| KYICENQDSISSKLK | 286 | P02768 | |
| FTKLDADKSYQCLKE | 381 | O14757 | |
| EKKNSVVEASEAAYK | 141 | Q04917 | |
| TLYNEHKSCEEKSVK | 446 | P49761 | |
| KCEFQDAYVLLSEKK | 236 | P10809 | |
| RSKEKLDCELQKDYS | 111 | O94985 | |
| SECVDKIKEKDKLYS | 861 | Q6UB98 | |
| KSLVGCKKSEENYQD | 1206 | Q9UKL3 | |
| ESICTTKYLEAEKIK | 191 | P0C7W6 | |
| KEYLEQSCPKAIKTE | 1631 | Q9C0F0 | |
| EKVNKCEYKLASEFI | 1481 | Q9NRL2 | |
| KEEGKNSSKCYIQVT | 481 | Q04656 | |
| EDLVEKYCEKSITVK | 366 | Q7Z5Q5 | |
| EVKEEDAFYSKKCKL | 351 | Q9UKX7 | |
| CDLTTKKVVDYTTAK | 126 | P62820 | |
| YKEKACEIRDQITSK | 216 | Q92878 | |
| CDNDITEKVSFLEKK | 336 | Q86YS3 | |
| SSKNDISKVCRKEYE | 121 | O95980 | |
| SIVDNEKCKYLTKPE | 951 | Q8TE59 | |
| VYNDCAKKIVKDVLE | 61 | P33176 | |
| DKSEKAYSSNEVEKC | 136 | Q9H1A4 | |
| ADESLKKQNEYVEKC | 551 | Q6TGC4 | |
| YATEKKTVDCSKNRI | 596 | Q9P2G4 | |
| ELKQYDNKIIECKFE | 506 | O60942 | |
| KYKVTCQSSELAKDI | 676 | Q09328 | |
| NVQKAIDKYTCKSLS | 216 | A5PLN7 | |
| EKVKREAVQELCSEY | 556 | Q9NQ38 | |
| SLETAKAIKEKYCYI | 91 | Q9C0K3 | |
| QTKDTVAKKVYLLCE | 1756 | O43451 | |
| KKEDNRYSDLKTIIC | 671 | O43525 | |
| YKDSKETCAVLQKVA | 336 | Q8N3X6 | |
| KQVAYIFKCEKSTIQ | 351 | P40123 | |
| KENVKYKIVAISCAA | 1626 | Q5VYK3 | |
| SCTKAYKKETNETKE | 76 | Q6Q8B3 | |
| YKKETNETKETNCTV | 81 | Q6Q8B3 | |
| TQKTFKVKDKVQYEC | 166 | P05160 | |
| DKYCVQQLKELESKT | 211 | Q58FG0 | |
| LKVVQTKYVEAKDCL | 36 | Q99471 | |
| TKYVEAKDCLNVLNK | 41 | Q99471 | |
| TYKCTVIVNNKEKTT | 106 | P16284 | |
| CYQAITKKLKICEEE | 231 | Q49A26 | |
| ELTQGVTCYKAKIKE | 1151 | Q96Q89 | |
| VTCYKAKIKELETIL | 1156 | Q96Q89 | |
| YKEEAEIICDKVQVK | 41 | Q8TBE9 | |
| KFCKTYIEDLVKEAT | 626 | Q8IUZ0 | |
| KKIFDDAYKSQLSCV | 586 | P46459 | |
| KAYKKETNETKETNC | 86 | Q8TD46 | |
| SKEIDKCLSREKTYV | 31 | Q14344 | |
| QKEKKLNIYTCLASD | 741 | Q9P2E7 | |
| EENISEVKSYKCLKV | 336 | Q96RD7 | |
| CETVKDFVAKVEKTY | 516 | Q86XP1 | |
| NYLKEICESEKKAHT | 61 | Q2M2Z5 | |
| VKKIEISQHAKYTCS | 26 | P61513 | |
| GSYISEVKEVLQECK | 81 | Q01658 | |
| YEKQICDKLAVEETK | 216 | Q9BXJ9 | |
| SSKENTRTVEKLYKC | 41 | Q49AM1 | |
| DVYKAKCEIQEKVYT | 516 | Q460N5 | |
| KVEEANELYKVCVTN | 381 | Q52LW3 | |
| KKSQKETESLHCEYV | 121 | P87889 | |
| KKSQKETESLHCEYV | 121 | Q9YNA8 | |
| KKSQKETESLHCEYV | 121 | P63145 | |
| KKSQKETESLHCEYV | 121 | P62685 | |
| KKSQKETESLHCEYV | 121 | P63126 | |
| KKSQKETESLHCEYV | 121 | P62684 | |
| QKYQELTQECDEKKS | 516 | Q8WYA0 | |
| YARVKEECLKSDAQK | 116 | Q9Y2F5 | |
| NEIKSYCYVSKEELK | 166 | Q13907 | |
| SAVEKKLAEYKCNTN | 16 | O14929 | |
| KKDSIACTYSNKNDV | 346 | A2AJT9 | |
| QAVLCSKDKTYDLKI | 71 | Q9BVC3 | |
| CEKSKNQVKEKYSFV | 341 | P51587 | |
| VISQDLDYKEAKCNK | 681 | P51587 | |
| FCLQLSKSYEKVEKA | 291 | Q5THR3 | |
| SEEVYCLQKELKIKN | 761 | Q5T9S5 | |
| VVEVTLSYKSKQFCK | 316 | Q9BQW3 | |
| VEKYLKVCKTEDEAV | 51 | P0C843 | |
| KVCKTEDEAVYKAKI | 56 | P0C843 | |
| TYLDKVENTCKKFAN | 116 | Q5T764 | |
| ASEKNIQKKYECELE | 286 | Q8IWJ2 | |
| SDAQIYVDKVKQTCK | 111 | O14879 | |
| YQKCTTVDEAEKAIE | 626 | Q6IQ26 | |
| RKLDYKCFSEKDQTQ | 71 | A0A1W2PPF3 | |
| EYICKRNEEIKKAQE | 156 | Q8TC29 | |
| KSYLKEKDTTVICST | 221 | O00458 | |
| EKVSYVIKKLKEDCH | 691 | Q6ZN28 | |
| KASDAEKVYGECSQK | 456 | Q8TF76 | |
| LKEYVDCLTDKSAKT | 141 | Q12894 | |
| TYLDKVENICKKLSN | 116 | P09914 | |
| DSLSKKITQVYKVCI | 431 | Q502W7 | |
| EKFVDELCISYSAKK | 21 | Q6ZST2 | |
| VCSSKTYKEKVDADT | 1171 | Q5T890 | |
| VELTKKLTYCVKAEL | 996 | Q8TDG4 | |
| DLQCNTVLKTKYDKV | 871 | Q86UP8 | |
| DLQCNTVLKTKYDKV | 871 | Q6EKJ0 | |
| KLEAVYKEFELQKVC | 656 | O94887 | |
| AKKKVAEFQKQCEEY | 3031 | Q9P225 | |
| ICKDYSIVKELAKHT | 411 | Q7Z3Z3 | |
| KEAKQVLCYAASVNK | 331 | Q9Y267 | |
| YAVKCNDSKAIVKTL | 66 | P11926 | |
| CVKKTSTQEYAAKII | 31 | Q13555 | |
| IKIYFDSDAKIEECK | 261 | Q8IZK6 | |
| KECSSKEEYQKESSA | 531 | Q8IZK6 | |
| VYVIDSCKQKVKLFT | 726 | Q08211 | |
| KYKEEIEDICISAVK | 1526 | Q8TE73 | |
| ITGVKLKEVECYNVK | 446 | Q86V97 | |
| KEQDVSKETVFCKYN | 906 | Q5THK1 | |
| STVDFLKIKKSCEEN | 1121 | Q5THK1 | |
| QKYIAESKCLVIEKN | 81 | Q0VDF9 | |
| TDKLCSQKDFVTKVE | 566 | Q8IVF1 | |
| IDKLCSQKDFVTKVE | 566 | A6NNL0 | |
| IDKLCSQKDFVTKVE | 566 | B1AL46 | |
| RKYKKECEEEAINIQ | 271 | P46939 | |
| EKACSDELTVYKVQN | 1546 | Q92673 | |
| DVCQGYKEKLQKAVT | 131 | O00635 | |
| KNEESLKKCVEDYLA | 741 | Q9Y6A5 | |
| QIKSEYKEERCTEKN | 2526 | Q8WUY3 | |
| QKLCEDVKIQYTDTK | 211 | Q96DU3 | |
| YEKQLDETVVSCKKA | 636 | Q8N4C6 | |
| EDDVVKKGAICTSKY | 171 | Q9HB63 | |
| IEYEKVDKATKNTLC | 196 | P58417 | |
| LYVTIKDEKVCVNDD | 186 | Q587J7 | |
| TEKKEYDEKNSCVKL | 361 | Q587J7 | |
| VKLCKAYQEAGEKVS | 251 | Q9UL41 | |
| ESCDQILDSYKVVKK | 971 | Q562F6 | |
| NCYAKVITVESQKKI | 1911 | Q9UPS6 | |
| AVECLFSKDSEIKKV | 21 | Q99697 | |
| ETKVKGKENECKDIY | 641 | P46721 | |
| GKENECKDIYQKSTV | 646 | P46721 | |
| CKDIYQKSTVLKDDE | 651 | P46721 | |
| VVLFEKKVYLSECKT | 91 | P00747 | |
| CKISLVDKTKQVSTY | 271 | O43556 | |
| AAIEAFNKCKTIYEK | 206 | Q9UHB9 | |
| KKSQKETESLHCEYV | 121 | P63128 | |
| EAYVQKLVKVCTDSD | 171 | Q96A09 | |
| EAYVQKLVKVCTDTD | 136 | Q5VWP2 | |
| SLKEAVCEVALDYKK | 2256 | Q01082 | |
| QSKLSKTEEYSKECL | 491 | Q8TBZ0 | |
| QVTEICDAYTKKLNE | 111 | Q14690 | |
| KQYTEAVKDCTEALK | 241 | Q15785 | |
| LAELYEDEVKCKSSK | 31 | Q14CS0 | |
| IKYCESIESGKTVNK | 246 | Q14587 | |
| IKKDAETNEAIYCTK | 281 | Q6GYQ0 | |
| IEQLQEKYKTELCTK | 121 | Q9H081 | |
| ENLVVCVKYGTKIKE | 1586 | Q13129 | |
| YLKIQKYEEAEKDCT | 326 | Q9H6T3 | |
| YNDTIAAKQEKCKTF | 151 | Q8N4C7 | |
| NIKKKECVYFVESSK | 66 | O94759 | |
| KKYILSKDVNTATCD | 741 | Q9BX26 | |
| VSKCDPNKVEKYLEQ | 216 | Q9HCK1 | |
| ACSDQDNVYKKSVKR | 1076 | Q8IZM8 | |
| LKEIDKTSFYSICNK | 126 | Q9HBJ7 | |
| CVDKLEKELVSKYRQ | 161 | Q5SRE5 | |
| DYVEKIKASGTKEIC | 1256 | Q92576 | |
| YKTQVRELKEECEEK | 876 | O75116 | |
| KESQAKDVIEEYFKC | 116 | P25398 | |
| IEECVESGKSYYKVK | 76 | M5A8F1 | |
| TIAEAKCDVEYSNKT | 2126 | Q86WI1 | |
| VNTCNEVYELKKKVI | 201 | A6NFE2 | |
| KVITKEEKENIYEVC | 991 | Q8N9V7 | |
| EEKENIYEVCKSKDS | 996 | Q8N9V7 | |
| KLVCTKTYHTEKAED | 121 | Q99805 | |
| SIDVQDVYTKVKCKI | 1361 | Q7Z7G8 | |
| DVYTKVKCKIESFNI | 1366 | Q7Z7G8 | |
| TQSKIFQCDKYVKVA | 141 | Q03923 | |
| DCEKAIAIDSKYSKA | 141 | Q96EQ0 | |
| DQKCVETVELGSYEK | 56 | Q8TD55 | |
| SERSCIYEEKLKKQQ | 121 | Q96LW1 | |
| YKSKENCVVDNIKVC | 841 | Q9H9Y6 | |
| KEKQLETSCKEKTEY | 221 | Q8IY18 | |
| KEKYSEIQQLLKCVS | 2416 | Q68DK2 | |
| CSYEEVKEVFENKEK | 41 | Q9BZD7 | |
| EEKIKCLATEKVKYT | 466 | P45974 | |
| TEEKFYKIECDKDLS | 326 | Q9UL59 | |
| RDEKIYSDKGCKTVQ | 316 | O14657 | |
| AYAKKDTREVVAIKC | 31 | Q6PHR2 | |
| KQNCTKRYITKEDVA | 826 | Q5FWF4 | |
| KAKESIRAKCVQYLD | 51 | Q9UN37 | |
| CLAEIKQTEEKYTET | 196 | Q9UKW4 | |
| YSEKCVTSKCQEIEI | 1046 | Q14789 | |
| VDEQNKDYKCLVEKL | 936 | Q9Y4I1 | |
| QELSFSDKKEVCKVV | 706 | Q9NQX4 | |
| KDCSEVERTYLKTKS | 1096 | Q12879 | |
| TQEYEAIKKLDQCKD | 476 | P20929 | |
| LAKKCQTLVSDVDYK | 2611 | P20929 | |
| AKKCQTLVSDVDYKH | 3341 | P20929 |